ID	Description	GeneRatio	BgRatio	pvalue	p.adjust	qvalue	geneID	Count
R-HSA-5663202	Diseases of signal transduction	170/874	326/4579	1.49240198439262e-44	1.69686105625441e-41	8.76589797148509e-42	60/6868/207/208/10000/324/369/374/408/8312/572/10018/673/801/805/808/815/816/817/818/842/867/1024/1026/1027/1147/1385/1387/1445/1452/1487/1499/8454/28514/1950/1956/2033/2064/2065/2066/2099/2100/55294/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2335/2308/2309/4303/10818/2534/8322/7855/8323/8325/2549/9846/2885/2931/2932/2962/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/3082/3265/3320/3667/8660/3674/3690/182/3717/2648/8850/3815/3845/8844/3932/4040/9208/5604/5605/5594/5595/4193/4233/2475/4609/9611/9612/4851/3164/4893/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5335/5431/5432/5439/5515/5518/5519/5528/5663/5687/5688/5694/5717/5728/5781/5879/5880/5894/5906/5908/3516/9978/6199/6464/6500/4087/4088/4089/6654/6714/6772/6774/6776/6777/79718/6934/7039/7040/7046/7048/8805/7314/7409/89780/7529/9372	170
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	192/874	397/4579	3.07088134321652e-44	1.74579604361859e-41	9.01869362902537e-42	60/6868/207/208/10000/1173/374/382/466/558/9564/627/673/801/805/808/857/867/998/1020/1111/1278/1385/1398/1399/1445/1495/1499/1500/6387/1729/1793/1950/1956/2002/2064/2065/2066/2099/2241/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2321/2322/2324/2335/10818/2534/2549/9846/10750/2887/2885/2962/3082/9146/3265/3320/3315/3479/3480/3643/3667/8660/8471/83737/3673/3675/3685/3688/3690/3717/3791/3815/3845/284217/3932/4067/5604/5605/5594/5600/6300/5603/1432/5595/5598/9261/4205/4208/4233/4318/4486/2475/653361/4690/9611/25920/4893/3084/4915/55824/5058/5062/5155/80310/5156/5159/5289/5290/5291/5295/5296/8503/5327/5335/5431/5432/5439/5515/5518/5519/5528/5566/5567/5578/5579/5580/5581/5590/5663/5725/5747/2185/5753/5781/5782/5771/5777/5795/5829/5879/5906/5908/2889/5921/23543/387/6195/6196/6197/9252/6464/25759/53358/8651/6654/8877/6696/6714/6772/6774/6776/6777/6778/3925/10273/23118/7039/7314/7409/7410/10451/7422/7424/11059/10413/7525/7529	192
R-HSA-449147	Signaling by Interleukins	178/874	407/4579	1.98963780808963e-33	7.54072729265971e-31	3.89550139268075e-31	207/301/302/351/375/466/1386/596/598/8945/836/867/6347/595/1230/1234/920/998/1026/1147/1278/1385/1398/1399/1436/1437/1438/1439/8454/2919/2002/356/2247/2335/2353/2308/2309/2534/9846/2625/2885/3082/3091/3162/3320/7184/3312/3383/3458/3551/8517/3586/3592/3593/3594/3595/3596/3605/3606/3553/3554/3557/3559/3560/3561/9235/3563/3565/3566/3567/3569/3572/3635/3667/8660/3684/3688/3689/3716/3717/3718/3725/3726/3932/3976/4067/5604/6416/5608/4215/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4282/4312/4313/4318/4478/4609/4790/4792/4843/5062/27250/5290/5291/5293/5295/5296/8503/5292/5443/5451/5515/5518/5519/5528/5566/5687/5688/5694/5717/5724/5743/2185/5781/5782/5771/5777/5778/5908/2889/9978/5970/6195/6196/6197/9252/6288/6382/6464/6500/4088/8651/8835/9021/9655/6648/6654/6772/6773/6774/6776/6777/6778/6850/10454/23118/7040/7124/7132/7157/7189/7297/7314/7409/7422/7525/7534	178
R-HSA-2219528	PI3K/AKT Signaling in Cancer	68/874	92/4579	1.07059919622455e-30	3.0431782152683e-28	1.57209039866658e-28	207/208/10000/374/572/842/1026/1027/1147/1385/1950/1956/2064/2065/2066/2099/2100/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2308/2309/4303/10818/2534/2549/2885/2931/2932/3082/3667/8660/3815/3932/4193/4233/2475/3164/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5728/5781/5879/5880/6199/6714/7039/7409	68
R-HSA-9006925	Intracellular signaling by second messengers	122/874	262/4579	1.2206896747245e-25	2.53354702618203e-23	1.30881751665007e-23	107/108/113/207/208/10000/374/1386/572/801/805/808/815/816/817/818/814/84254/10645/842/1026/1027/1147/1385/1457/1950/1956/1958/2064/2065/2066/2099/2100/2146/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2308/2309/4303/10818/2534/2549/2885/2931/2932/3065/3066/8841/10014/51564/3082/3643/3667/8660/3725/3815/3932/5594/5595/4193/4233/9112/2475/3164/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5335/5371/5468/5515/5518/5519/5528/5566/5567/5573/5577/5578/5580/5581/5582/5613/5687/5688/5694/5717/5728/5781/5879/5880/5928/6199/57521/6615/6714/10273/7039/7157/7189/7314/7409	122
R-HSA-5683057	MAPK family signaling cascades	117/874	246/4579	1.33696412991136e-25	2.53354702618203e-23	1.30881751665007e-23	60/369/374/408/673/801/805/808/815/816/817/818/896/998/983/1437/1438/1439/1445/153090/1950/1956/2064/2065/2066/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/2335/2308/2309/10818/2534/2674/2885/3082/3265/3315/3559/3560/3561/3563/3567/3569/3572/3667/8660/3674/3690/3716/3717/3718/3725/3815/3845/8844/27040/5604/5605/5594/5595/5597/8550/4233/4609/8202/4893/3084/5058/5062/5155/5156/5159/5515/5518/5519/5528/5566/5567/5687/5688/5694/5717/5747/5781/5879/5894/5906/5908/5921/5923/9978/5979/6464/25759/53358/6654/6714/7010/7039/7297/7314/7514/7529	117
R-HSA-8939211	ESR-mediated signaling	87/874	166/4579	9.07609121261778e-23	1.47421652982092e-20	7.61572766412139e-21	207/208/10000/374/1386/8312/596/801/805/808/857/595/1025/1027/4435/1385/1387/6387/1655/1950/1956/2002/2033/2066/2099/2100/2288/2353/2354/3169/2309/2625/2770/2773/2782/2783/10681/54331/2962/3014/3015/3020/3021/3065/3265/3320/3326/3315/3480/3725/3727/8850/10524/3845/5594/5595/4313/4318/4609/8648/10499/8202/4893/8204/5290/5295/5296/8503/5431/5432/5439/5451/5590/5747/6464/9126/6667/8877/6714/6722/6908/7031/7033/7039/7391/7514/7528	87
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	49/874	66/4579	1.66108131664398e-22	2.36081182128026e-20	1.2195833877465e-20	374/1950/1956/2064/2065/2066/2099/2100/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/10818/2534/2549/2885/3082/3667/8660/3815/3932/4233/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5781/5879/5880/6714/7039/7409	49
R-HSA-6785807	Interleukin-4 and Interleukin-13 signaling	63/874	101/4579	4.13031542017398e-22	5.03732259104702e-20	2.602255247701e-20	207/301/596/598/6347/595/1026/1278/356/2247/2335/2353/2308/2309/2625/3082/3091/3162/3320/7184/3312/3383/3586/3592/3593/3596/3605/3606/3553/3561/3565/3566/3569/3684/3688/3689/3716/3717/3718/3726/3976/4312/4313/4318/4609/4843/5295/5292/5443/5451/5743/6288/8651/9021/9655/6772/6774/6778/7040/7124/7157/7297/7422	63
R-HSA-9607240	FLT3 Signaling	107/874	232/4579	4.43036287691031e-22	5.03732259104702e-20	2.602255247701e-20	60/208/369/374/408/673/801/805/808/815/816/817/818/1437/1438/1439/1445/153090/1950/1956/2064/2065/2066/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/2335/10818/2534/2549/9846/2674/2885/3082/3265/3559/3560/3561/3563/3567/3667/8660/3674/3690/3716/3717/3718/3815/3845/8844/27040/5604/5605/5594/5595/4233/4893/3084/5155/5156/5159/5289/5290/5291/5295/5296/5515/5518/5519/5528/5687/5688/5694/5717/5747/5781/5894/5906/5908/5921/5923/9978/5979/6464/25759/53358/6654/6714/6776/6777/7010/7039/7314/7529	107
R-HSA-74751	Insulin receptor signalling cascade	38/874	45/4579	2.73087071489378e-21	2.82272727530384e-19	1.45820656355093e-19	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2887/2885/3265/3643/3667/8660/3845/5594/5595/4893/5289/5290/5291/5295/5296/5781/6464/6654	38
R-HSA-199418	Negative regulation of the PI3K/AKT network	61/874	99/4579	4.88043088250128e-21	4.62420826116996e-19	2.38884248459273e-19	207/208/10000/374/1950/1956/2064/2065/2066/2099/2100/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/10818/2534/2549/2885/3082/3643/3667/8660/3815/3932/5594/5595/4233/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5515/5518/5519/5528/5728/5781/5879/5880/6714/7039/7189/7409	61
R-HSA-187037	Signaling by NTRK1 (TRKA)	50/874	72/4579	8.06040724464665e-21	7.04975618243326e-19	3.641868212561e-19	1173/466/673/1385/1398/1399/2002/10818/2885/3265/3667/8660/3845/5604/5605/5594/5600/6300/5603/1432/5595/5598/9261/4205/4208/4893/4915/5290/5291/5295/5296/5335/5515/5518/5519/5528/5906/2889/387/6195/6196/6197/9252/6464/25759/53358/6654/6714/6774/7529	50
R-HSA-6811558	PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling	58/874	92/4579	9.15786556033679e-21	7.4374951015021e-19	3.8421721674195e-19	207/374/1950/1956/2064/2065/2066/2099/2100/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/10818/2534/2549/2885/3082/3643/3667/8660/3815/3932/5594/5595/4233/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5515/5518/5519/5528/5781/5879/5880/6714/7039/7189/7409	58
R-HSA-9006931	Signaling by Nuclear Receptors	97/874	207/4579	1.13080058607512e-20	8.57146844244942e-19	4.4279770317889e-19	207/208/10000/374/1386/8312/596/801/805/808/857/595/1025/1027/4435/1385/1387/6387/1655/1950/1956/2002/2033/2066/2099/2100/2288/2353/2354/3169/2309/2625/2770/2773/2782/2783/10681/54331/2962/3014/3015/3020/3021/3065/8841/3265/3320/3326/3315/3480/3725/3727/8850/10524/3845/5594/5595/4313/4318/4609/8648/10499/8202/9611/9612/4893/8204/5163/5290/5295/5296/8503/5431/5432/5439/5451/5590/5747/5914/5916/6256/6257/6464/9126/6667/8877/6714/6720/6722/79718/6908/7031/7033/7039/7391/7514/7528	97
R-HSA-512988	Interleukin-3, Interleukin-5 and GM-CSF signaling	38/874	46/4579	1.28845153675977e-20	9.15605873309912e-19	4.72997340468389e-19	867/1398/1399/1437/1438/1439/2534/9846/2885/3559/3560/3561/3563/3567/3635/3716/3717/3718/4067/5290/5291/5293/5295/5296/8503/5566/5781/5777/2889/6464/6654/6776/6777/6850/7314/7409/7525/7534	38
R-HSA-166520	Signaling by NTRKs	57/874	90/4579	1.44611570445254e-20	9.67196209389725e-19	4.99648645872765e-19	1173/466/627/673/1020/1385/1398/1399/2002/10818/2534/2549/2885/3265/3667/8660/3845/5604/5605/5594/5600/6300/5603/1432/5595/5598/9261/4205/4208/25920/4893/4915/5290/5291/5295/5296/5335/5515/5518/5519/5528/5781/5879/5906/2889/387/6195/6196/6197/9252/6464/25759/53358/6654/6714/6774/7529	57
R-HSA-5684996	MAPK1/MAPK3 signaling	101/874	221/4579	1.70754216121719e-20	1.07859746516886e-18	5.57197968397189e-19	60/369/374/408/673/801/805/808/815/816/817/818/983/1437/1438/1439/1445/153090/1950/1956/2064/2065/2066/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/2335/10818/2534/2674/2885/3082/3265/3559/3560/3561/3563/3567/3569/3572/3667/8660/3674/3690/3716/3717/3718/3815/3845/8844/27040/5604/5605/5594/5595/4233/4893/3084/5155/5156/5159/5515/5518/5519/5528/5687/5688/5694/5717/5747/5781/5894/5906/5908/5921/5923/9978/5979/6464/25759/53358/6654/6714/7010/7039/7297/7314/7529	101
R-HSA-194138	Signaling by VEGF	62/874	104/4579	2.67215033075157e-20	1.59907101371818e-18	8.2607195820464e-19	60/207/208/10000/558/9564/801/805/808/857/998/1398/1495/1499/1500/1793/2321/2324/2534/3265/3320/3315/3685/3690/3791/3845/5600/6300/5603/1432/9261/2475/653361/4690/4893/5058/5062/5290/5291/5295/5296/5335/5566/5567/5578/5579/5580/5590/5747/2185/5829/5879/5921/387/25759/8877/6714/7409/7410/10451/7422/7424	62
R-HSA-4420097	VEGFA-VEGFR2 Pathway	59/874	97/4579	5.60473624445197e-20	3.12581939255368e-18	1.6147824108179e-18	60/207/208/10000/558/9564/801/805/808/857/998/1398/1495/1499/1500/1793/2534/3265/3320/3315/3685/3690/3791/3845/5600/6300/5603/1432/9261/2475/653361/4690/4893/5058/5062/5290/5291/5295/5296/5335/5566/5567/5578/5579/5580/5590/5747/2185/5829/5879/5921/387/25759/8877/6714/7409/7410/10451/7422	59
R-HSA-2428924	IGF1R signaling cascade	37/874	45/4579	5.77328119996721e-20	3.12581939255368e-18	1.6147824108179e-18	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2885/3265/3479/3480/3667/8660/8471/3845/4893/5289/5290/5291/5295/5296/5781/6464/6654	37
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	37/874	46/4579	2.421091425982e-19	1.25126406879161e-17	6.46396658228688e-18	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2885/3265/3479/3480/3667/8660/8471/3845/4893/5289/5290/5291/5295/5296/5781/6464/6654	37
R-HSA-2428928	IRS-related events triggered by IGF1R	36/874	44/4579	2.57246483344239e-19	1.27169239809739e-17	6.56949829318469e-18	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2885/3265/3479/3480/3667/8660/8471/3845/4893/5289/5290/5291/5295/5296/5781/6654	36
R-HSA-1257604	PIP3 activates AKT signaling	99/874	225/4579	1.21802412599928e-18	5.64631443786364e-17	2.91685734048782e-17	207/208/10000/374/1386/572/842/1026/1027/1147/1385/1457/1950/1956/1958/2064/2065/2066/2099/2100/2146/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2308/2309/4303/10818/2534/2549/2885/2931/2932/3065/3066/8841/10014/51564/3082/3643/3667/8660/3725/3815/3932/5594/5595/4193/4233/9112/2475/3164/3084/5155/5156/5159/5290/5291/5293/5295/5296/8503/5371/5468/5515/5518/5519/5528/5687/5688/5694/5717/5728/5781/5879/5880/5928/6199/57521/6615/6714/10273/7039/7157/7189/7314/7409	99
R-HSA-5673001	RAF/MAP kinase cascade	96/874	215/4579	1.24149393972376e-18	5.64631443786364e-17	2.91685734048782e-17	60/369/374/408/673/801/805/808/815/816/817/818/1437/1438/1439/1445/153090/1950/1956/2064/2065/2066/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/2335/10818/2534/2674/2885/3082/3265/3559/3560/3561/3563/3567/3667/8660/3674/3690/3716/3717/3718/3815/3845/8844/27040/5604/5605/5594/5595/4233/4893/3084/5155/5156/5159/5515/5518/5519/5528/5687/5688/5694/5717/5747/5894/5906/5908/5921/5923/9978/5979/6464/25759/53358/6654/6714/7010/7039/7314/7529	96
R-HSA-112399	IRS-mediated signalling	33/874	40/4579	5.22149690471459e-18	2.2834007617925e-16	1.1795932278667e-16	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2885/3265/3667/8660/3845/4893/5289/5290/5291/5295/5296/5781/6654	33
R-HSA-9009391	Extra-nuclear estrogen signaling	47/874	72/4579	6.22359034901847e-18	2.62082304697556e-16	1.35390386540051e-16	207/208/10000/374/596/801/805/808/857/595/1027/1385/1950/1956/2002/2099/2100/2353/2309/2770/2773/2782/2783/10681/54331/3265/3320/3315/3480/3845/5594/5595/4313/4318/4893/5290/5295/5296/8503/5590/5747/6464/8877/6714/6722/7039/7514	47
R-HSA-2559583	Cellular Senescence	68/874	130/4579	6.5905442810926e-18	2.67623173128653e-16	1.38252771009386e-16	64682/10393/51529/29882/29945/51433/472/8900/890/898/9134/8881/8697/246184/996/1017/1019/1021/1026/1027/1029/1051/1869/2113/2114/2146/2353/51343/3014/3015/3020/3021/3159/3569/3725/10524/6416/5608/4217/9448/5594/5602/5600/1432/5595/5598/5599/5601/9261/8550/4193/4194/4790/5925/5928/5970/6195/6196/6197/6667/6774/7027/7029/7157/7295/7314/11065/7321	68
R-HSA-76002	Platelet activation, signaling and aggregation	83/874	182/4579	6.93731243281401e-17	2.71990490900328e-15	1.40508905172785e-15	207/351/408/9564/801/805/808/998/1191/1278/1398/1445/1950/2149/2207/2335/2534/2767/2768/10672/9630/2769/2770/2773/2776/2782/2783/10681/54331/2885/3082/3479/3674/3690/27040/3932/3937/4067/5594/1432/5595/5155/5290/5291/5294/5295/5296/8503/23533/5578/5579/5580/5581/5582/5588/5590/5747/5781/5777/5879/5880/5894/5906/5908/10235/387/388/5054/6464/6654/6714/6850/6915/7040/7042/7043/7114/7409/7410/10451/7422/7424/7534	83
R-HSA-1433557	Signaling by SCF-KIT	33/874	42/4579	8.40566018963866e-17	3.17844918605085e-15	1.6419706946409e-15	867/1111/2241/2534/9846/10750/2887/2885/3265/3717/3815/3845/3932/4067/4318/4893/5290/5295/5296/8503/5578/5781/5777/5879/8651/6654/6714/6772/6774/6776/6777/7409/7525	33
R-HSA-5654696	Downstream signaling of activated FGFR2	24/874	25/4579	8.6659564439381e-17	3.17844918605085e-15	1.6419706946409e-15	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2549/2885/3265/3845/4893/5290/5295/5335/5781/6464/6654	24
R-HSA-186763	Downstream signal transduction	26/874	29/4579	2.96700988317899e-16	1.05421569911703e-14	5.44602471978249e-15	9564/1398/1399/2885/3265/3845/4690/4893/5155/5156/5159/5290/5291/5295/5296/5335/5781/2889/5921/6654/6714/6772/6774/6776/6777/6778	26
R-HSA-2871796	FCERI mediated MAPK activation	27/874	31/4579	3.90383139604724e-16	1.34504736281991e-14	6.94844631258169e-15	2207/2353/2885/3265/3725/3845/27040/3937/4067/6416/4214/5594/5602/5595/5599/5601/4893/5058/5062/5335/5879/6464/6654/6850/7409/7410/10451	27
R-HSA-9006335	Signaling by Erythropoietin	23/874	24/4579	4.45467384733475e-16	1.47125821147148e-14	7.60044514188852e-15	1399/2057/2549/2885/3265/8660/3717/3845/4067/4893/5290/5291/5293/5294/5295/23533/5335/2889/6464/6654/6776/6777/7409	23
R-HSA-5654741	Signaling by FGFR3	30/874	37/4579	4.52893908544432e-16	1.47125821147148e-14	7.60044514188852e-15	673/867/2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2549/2885/3265/3845/5594/5595/4893/5290/5295/5335/5515/5518/5781/6464/6654/6714/7314	30
R-HSA-74752	Signaling by Insulin receptor	38/874	55/4579	5.67932218723479e-16	1.79371925746832e-14	9.26626251601466e-15	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2887/2885/3265/3643/3667/8660/3845/5594/5595/4893/5289/5290/5291/5295/5296/5781/6464/6654	38
R-HSA-109582	Hemostasis	139/874	395/4579	1.67302311788817e-15	5.14115482442931e-14	2.65589445172574e-14	25/60/207/302/351/408/9564/801/805/808/857/23468/914/960/998/1017/1020/1191/1278/1398/1445/1793/1950/2149/2207/2268/2335/2534/2625/2767/2768/10672/9630/2769/2770/2773/2776/2782/2783/10681/54331/2885/3020/3021/3065/3066/3082/3265/3479/3635/3672/8515/3673/3674/3675/3676/3678/3655/3684/3685/3688/3689/3690/3717/3845/27040/3932/3937/4067/5594/1432/5595/4282/4312/4842/4843/4893/5155/5290/5291/5294/5295/5296/8503/23533/5327/5335/5515/5518/5519/5528/5566/5567/5573/5577/5578/5579/5580/5581/5582/5588/5590/10544/5747/5781/5777/5879/5880/5894/5906/5908/10235/387/388/6382/6383/6385/6402/5054/6464/25942/6654/6714/6850/6915/7010/7040/7042/7043/7114/7157/7409/7410/10451/7422/7424/7465/7525/7534	139
R-HSA-166166	MyD88-independent TLR4 cascade 	54/874	99/4579	1.80960418465748e-15	5.27569219988605e-14	2.72539577608334e-14	351/466/1386/8945/841/1147/1385/8454/2002/8772/2353/3551/9641/8517/3661/3725/5604/6416/5608/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5781/5970/8737/11035/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314/7321	54
R-HSA-937061	TRIF(TICAM1)-mediated TLR4 signaling 	54/874	99/4579	1.80960418465748e-15	5.27569219988605e-14	2.72539577608334e-14	351/466/1386/8945/841/1147/1385/8454/2002/8772/2353/3551/9641/8517/3661/3725/5604/6416/5608/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5781/5970/8737/11035/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314/7321	54
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	64/874	129/4579	1.95896587759432e-15	5.35441945427117e-14	2.76606587555739e-14	695/8945/801/805/808/1147/8454/2207/2353/2534/9846/2885/3265/3551/8517/3725/3845/27040/3937/4067/6416/4214/6885/5594/5602/5595/5599/5601/4772/4773/4775/4790/4792/4893/5058/5062/5290/5291/5295/5296/5335/5530/5532/5534/5588/5687/5688/5694/5717/5879/10235/5970/6464/6500/6654/6850/10454/23118/7189/7314/7321/7409/7410/10451	64
R-HSA-109704	PI3K Cascade	29/874	36/4579	1.97788581424265e-15	5.35441945427117e-14	2.76606587555739e-14	208/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/2322/10818/2549/9846/2885/3667/8660/5289/5290/5291/5295/5296/5781	29
R-HSA-5654743	Signaling by FGFR4	29/874	36/4579	1.97788581424265e-15	5.35441945427117e-14	2.76606587555739e-14	673/867/2246/8822/8817/2247/26281/8074/2253/2254/2264/10818/2549/2885/3265/3845/5594/5595/4893/5290/5295/5335/5515/5518/5781/6464/6654/6714/7314	29
R-HSA-5654708	Downstream signaling of activated FGFR3	22/874	23/4579	2.28381349648574e-15	6.03882778024253e-14	3.11962773816167e-14	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2549/2885/3265/3845/4893/5290/5295/5335/5781/6464/6654	22
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	52/874	94/4579	2.78836614107816e-15	7.20539159637698e-14	3.7222686763675e-14	351/466/1386/8945/841/1147/1385/8454/2002/8772/2353/3551/9641/8517/3661/3725/5604/6416/5608/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/8737/11035/6195/6196/6197/9252/6288/6500/10454/23118/148022/7189/7314/7321	52
R-HSA-5655332	Signaling by FGFR3 in disease	20/874	20/4579	3.44937180945075e-15	8.52594727683804e-14	4.40446102900118e-14	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2549/2885/3265/3845/4893/5290/5295/5335/6654	20
R-HSA-8853338	Signaling by FGFR3 point mutants in cancer	20/874	20/4579	3.44937180945075e-15	8.52594727683804e-14	4.40446102900118e-14	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2549/2885/3265/3845/4893/5290/5295/5335/6654	20
R-HSA-912526	Interleukin receptor SHC signaling	23/874	25/4579	4.57175731811556e-15	1.10597618525476e-13	5.71341676037734e-14	1437/1438/1439/9846/2885/3559/3560/3561/3563/3567/3635/3716/3717/3718/5290/5291/5293/5295/5296/8503/5777/6464/6654	23
R-HSA-5654736	Signaling by FGFR1	31/874	41/4579	5.0524795513048e-15	1.19680609371532e-13	6.18263945093876e-14	673/867/2246/8822/8817/2247/26281/27006/8074/2250/2253/2254/2260/10818/2549/2885/3265/3845/5594/5595/4893/5290/5295/5335/5515/5518/5781/6464/6654/6714/7314	31
R-HSA-451927	Interleukin-2 family signaling	30/874	39/4579	6.27559340291242e-15	1.45619381614519e-13	7.52262324129996e-14	1437/1438/1439/9846/2885/3559/3560/3561/3563/3567/3635/3716/3717/3718/3932/5290/5291/5293/5295/5296/8503/2185/5777/6464/6654/6772/6774/6776/6777/6850	30
R-HSA-1226099	Signaling by FGFR in disease	36/874	53/4579	7.89821777494156e-15	1.79605472202171e-13	9.2783274071945e-14	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/10818/2549/9846/2885/2962/3265/3845/9208/4893/5290/5295/5335/5431/5432/5439/6654/6772/6774/6776/6777/8805	36
R-HSA-5655302	Signaling by FGFR1 in disease	26/874	31/4579	9.29285158186476e-15	2.0717592644275e-13	1.07026030602281e-13	2246/8822/2247/26281/8074/2250/2253/2254/2260/10818/2549/9846/2885/3265/3845/9208/4893/5290/5295/5335/6654/6772/6774/6776/6777/8805	26
R-HSA-5654716	Downstream signaling of activated FGFR4	21/874	22/4579	1.16757859452932e-14	2.55295550380739e-13	1.31884383754527e-13	2246/8822/8817/2247/26281/8074/2253/2254/2264/10818/2549/2885/3265/3845/4893/5290/5295/5335/5781/6464/6654	21
R-HSA-450294	MAP kinase activation	40/874	64/4579	1.77158657986212e-14	3.8005546062325e-13	1.96334719277668e-13	466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/5515/5518/5519/5528/6195/6196/6197/9252/6500/10454/23118/7189/7314	40
R-HSA-5654687	Downstream signaling of activated FGFR1	22/874	24/4579	2.25056207257609e-14	4.73868347503522e-13	2.44797979824066e-13	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/10818/2549/2885/3265/3845/4893/5290/5295/5335/5781/6464/6654	22
R-HSA-448424	Interleukin-17 signaling	41/874	67/4579	2.36720176328452e-14	4.89365164519e-13	2.52803556729715e-13	466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3605/3725/5604/6416/5608/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/5515/5518/5519/5528/6195/6196/6197/9252/6500/10454/23118/7189/7314	41
R-HSA-9614085	FOXO-mediated transcription	37/874	57/4579	3.01561490818387e-14	6.12277526893761e-13	3.16299458414774e-13	207/208/10000/10018/847/857/1026/1027/1387/2033/356/2308/2309/4303/1647/2645/3065/3066/8850/9314/2908/5443/5934/2810/25942/23411/4087/4088/4089/6648/6720/6794/7295/7529/7532/10971/7534	37
R-HSA-190236	Signaling by FGFR	41/874	68/4579	4.89153338229776e-14	9.7573218520571e-13	5.04058287594118e-13	673/867/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2260/2263/2261/2264/10818/2549/2885/2962/3265/3845/5594/5595/4893/5290/5295/5335/5431/5432/5439/5515/5518/5725/5781/23543/6464/6654/6714/7314	41
R-HSA-9006936	Signaling by TGF-beta family members	49/874	91/4579	7.52421293126145e-14	1.47500519014556e-12	7.61980184327384e-13	91/94/650/657/658/659/867/1024/1025/1874/8928/3065/3726/4609/9611/9612/23327/142/5494/5590/387/54778/5054/6497/6498/4086/4087/4088/4089/4090/4091/4092/4093/64750/6667/11171/10273/7027/7029/7040/7046/7048/7050/7314/7321/51377/25937/7514/9372	49
R-HSA-5654695	PI-3K cascade:FGFR2	18/874	18/4579	9.80223353452016e-14	1.85752325479157e-12	9.5958707232671e-13	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2549/2885/5290/5295/5781	18
R-HSA-5654699	SHC-mediated cascade:FGFR2	18/874	18/4579	9.80223353452016e-14	1.85752325479157e-12	9.5958707232671e-13	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/2885/3265/3845/4893/6464/6654	18
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	59/874	122/4579	1.10999147900627e-13	2.0689513305412e-12	1.06880974164883e-12	351/466/1386/695/8945/841/1147/1385/8454/2002/8772/2353/3551/9641/8517/3661/3684/3689/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5781/5970/8737/11035/6195/6196/6197/9252/6288/6500/8651/10454/23118/148022/7099/7189/7314/7321	59
R-HSA-114604	GPVI-mediated activation cascade	26/874	33/4579	1.57391833322464e-13	2.88636313689744e-12	1.49108052621281e-12	998/1278/2207/2534/27040/3932/3937/4067/5290/5291/5294/5295/5296/8503/23533/5590/5781/5777/5879/5880/387/388/6850/7409/7410/10451	26
R-HSA-187687	Signalling to ERKs	25/874	31/4579	1.77415636062708e-13	3.15189965942655e-12	1.62825534412815e-12	673/1398/1399/10818/2885/3265/3845/5604/5605/5594/5600/6300/5603/1432/5595/9261/4893/5906/2889/6464/25759/53358/6654/6714/7529	25
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	25/874	31/4579	1.77415636062708e-13	3.15189965942655e-12	1.62825534412815e-12	466/1386/1385/2002/2353/3725/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/5515/5518/5519/5528/6195/6196/6197/9252	25
R-HSA-2424491	DAP12 signaling	24/874	29/4579	1.86954291197389e-13	3.27026198602202e-12	1.68940072045576e-12	567/695/2534/2885/3133/3265/22914/100528032/3845/27040/3932/3937/4893/5290/5291/5295/5296/5335/5879/6464/6654/6850/7410/10451	24
R-HSA-5654738	Signaling by FGFR2	38/874	62/4579	2.01915625597349e-13	3.47845555006343e-12	1.79695245746923e-12	673/867/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2549/2885/2962/3265/3845/5594/5595/4893/5290/5295/5335/5431/5432/5439/5515/5518/5725/5781/23543/6464/6654/6714/7314	38
R-HSA-1227986	Signaling by ERBB2	32/874	47/4579	2.3336811507644e-13	3.96029174390914e-12	2.04586658621608e-12	207/208/10000/1729/1950/1956/2064/2065/2066/2534/2549/2885/3265/3320/3845/4893/3084/5290/5295/5335/5578/5580/5581/5753/5782/387/6464/6654/6714/10273/7314/7525	32
R-HSA-5654700	FRS-mediated FGFR2 signaling	19/874	20/4579	3.02394928628516e-13	5.05622108603857e-12	2.61201811415963e-12	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2885/3265/3845/4893/5781/6654	19
R-HSA-2172127	DAP12 interactions	24/874	30/4579	7.67440474577546e-13	1.26460843419517e-11	6.53290289571733e-12	567/695/2534/2885/3133/3265/22914/100528032/3845/27040/3932/3937/4893/5290/5291/5295/5296/5335/5879/6464/6654/6850/7410/10451	24
R-HSA-109606	Intrinsic Pathway for Apoptosis	33/874	51/4579	8.85775309650702e-13	1.43875218153264e-11	7.43252064338484e-12	207/208/10000/317/572/596/598/10018/836/840/841/842/1029/54205/1869/5594/5595/5599/5533/5534/2810/6774/7027/7029/7157/8626/7161/7529/7531/7532/7533/10971/7534	33
R-HSA-69231	Cyclin D associated events in G1	30/874	44/4579	1.26607238159011e-12	1.99933930259438e-11	1.03284852182351e-11	25/595/894/896/902/1019/1021/1022/1026/1027/1028/1029/1163/8454/1869/1874/3717/4067/5515/5518/5519/5520/5753/5925/5934/6500/6714/7027/7029/7314	30
R-HSA-69236	G1 Phase	30/874	44/4579	1.26607238159011e-12	1.99933930259438e-11	1.03284852182351e-11	25/595/894/896/902/1019/1021/1022/1026/1027/1028/1029/1163/8454/1869/1874/3717/4067/5515/5518/5519/5520/5753/5925/5934/6500/6714/7027/7029/7314	30
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	45/874	85/4579	1.80604623809468e-12	2.73796609695153e-11	1.41441936962362e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/7189/7314	45
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	45/874	85/4579	1.80604623809468e-12	2.73796609695153e-11	1.41441936962362e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/7189/7314	45
R-HSA-975871	MyD88 cascade initiated on plasma membrane	45/874	85/4579	1.80604623809468e-12	2.73796609695153e-11	1.41441936962362e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/7189/7314	45
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	47/874	91/4579	1.87709587338107e-12	2.80823422109773e-11	1.45071952541085e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314	47
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	39/874	68/4579	1.96142296076573e-12	2.89628299531251e-11	1.4962050746511e-11	64682/10393/51529/29882/29945/51433/8900/890/8881/8697/246184/996/1017/1019/1021/1026/1027/1029/1051/2353/51343/3014/3015/3020/3021/3569/3725/5594/5595/5598/4790/5970/6195/6196/6197/6774/7314/11065/7321	39
R-HSA-5654704	SHC-mediated cascade:FGFR3	16/874	16/4579	2.77499806830607e-12	3.99388962489114e-11	2.06322308076587e-11	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/2885/3265/3845/4893/6464/6654	16
R-HSA-5654710	PI-3K cascade:FGFR3	16/874	16/4579	2.77499806830607e-12	3.99388962489114e-11	2.06322308076587e-11	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2549/2885/5290/5295/5781	16
R-HSA-166058	MyD88:MAL(TIRAP) cascade initiated on plasma membrane	48/874	95/4579	3.11006228770403e-12	4.26233802789817e-11	2.20190216133609e-11	351/466/1386/695/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/8651/10454/23118/7099/7189/7314	48
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	48/874	95/4579	3.11006228770403e-12	4.26233802789817e-11	2.20190216133609e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5289/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314	48
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	48/874	95/4579	3.11006228770403e-12	4.26233802789817e-11	2.20190216133609e-11	351/466/1386/695/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/8651/10454/23118/7099/7189/7314	48
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	47/874	92/4579	3.14895685438387e-12	4.26233802789817e-11	2.20190216133609e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314	47
R-HSA-975155	MyD88 dependent cascade initiated on endosome	47/874	92/4579	3.14895685438387e-12	4.26233802789817e-11	2.20190216133609e-11	351/466/1386/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/10454/23118/148022/7099/7189/7314	47
R-HSA-5654727	Negative regulation of FGFR2 signaling	23/874	29/4579	3.29061132337095e-12	4.40167655843855e-11	2.27388373800742e-11	673/867/2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2885/5594/5595/5515/5518/5781/6714/7314	23
R-HSA-3700989	Transcriptional Regulation by TP53	99/874	273/4579	4.34909115859861e-12	5.74990307828676e-11	2.97037070562793e-11	207/208/10000/317/1820/1386/472/545/6790/9212/580/641/672/843/835/839/8900/890/891/898/9134/902/983/1017/1020/1022/1025/1026/1027/1029/1111/11200/1387/1457/54205/1616/8445/1869/1874/2033/355/2353/1647/2962/2968/3065/3066/3486/3725/10524/5608/5600/1432/8550/9656/4193/4194/2475/25920/4869/5111/5300/1263/5371/5431/5432/5439/10848/5515/5518/5519/639/5052/5562/5563/5564/5728/5928/5934/57521/2810/6794/6872/6881/6908/7027/7029/11073/7157/8626/7161/7295/7314/7529/7531/7532/7533/10971/7534	99
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	62/874	141/4579	5.35759584097594e-12	7.00182353010303e-11	3.61710644799101e-11	367/6790/9212/641/672/23468/1029/1387/1487/1616/1655/2033/2099/3065/3066/9759/51564/3190/9641/8517/3619/9656/4193/4286/9112/8648/10499/9612/4792/4869/2908/2516/8204/9972/8021/4928/142/5111/8554/9063/10401/51588/5371/5465/5468/5905/5914/5970/6256/25942/9126/6672/7341/6613/6996/7020/7067/7157/10155/7329/7421/7428	62
R-HSA-2990846	SUMOylation	63/874	145/4579	6.83093995381058e-12	8.82588491759389e-11	4.55940728974438e-11	367/6790/9212/641/672/23468/1029/1387/1487/1616/1655/2033/2099/3065/3066/9759/51564/3190/9641/8517/3619/9656/4193/4286/9112/8648/10499/9612/4792/4869/2908/2516/8204/9972/8021/4928/142/5111/8554/9063/10401/51588/5371/5465/5468/5905/5914/5970/6256/29843/25942/9126/6672/7341/6613/6996/7020/7067/7157/10155/7329/7421/7428	63
R-HSA-5654706	FRS-mediated FGFR3 signaling	17/874	18/4579	7.72592145339833e-12	9.87008167698192e-11	5.09883402838116e-11	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2885/3265/3845/4893/5781/6654	17
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	48/874	97/4579	8.29077059217383e-12	1.03589078717601e-10	5.35135915608213e-11	351/466/1386/695/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/8651/10454/23118/7099/7189/7314	48
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	48/874	97/4579	8.29077059217383e-12	1.03589078717601e-10	5.35135915608213e-11	351/466/1386/695/8945/1147/1385/8454/2002/2353/3551/8517/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5515/5518/5519/5528/5970/6195/6196/6197/9252/6288/6500/8651/10454/23118/7099/7189/7314	48
R-HSA-111885	Opioid Signalling	43/874	82/4579	8.71915533104878e-12	1.07757387080462e-10	5.56669184751169e-11	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1020/1385/2770/2773/2775/2781/2782/2783/10681/54331/5594/5330/5331/5443/5515/5518/5519/5528/5530/5532/5533/5534/5566/5567/5573/5577/5578/5580/5582/5613	43
R-HSA-168898	Toll-like Receptor Cascades	61/874	139/4579	8.89902114338259e-12	1.08797710107807e-10	5.6204344063469e-11	351/466/1386/695/8945/841/1147/1385/8454/2002/8772/2353/7184/3551/9641/8517/3661/3684/3689/3725/5604/6416/5608/4214/6885/5594/5602/5600/1432/5595/5598/5599/5601/9261/4205/4208/4790/4792/5289/5515/5518/5519/5528/5781/5970/8737/11035/6195/6196/6197/9252/6288/6500/8651/10454/23118/148022/7099/7189/7314/7321	61
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	29/874	44/4579	1.11976781068432e-11	1.31255257809079e-10	6.7805799062599e-11	60/369/408/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	29
R-HSA-6802949	Signaling by RAS mutants	29/874	44/4579	1.11976781068432e-11	1.31255257809079e-10	6.7805799062599e-11	60/369/408/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	29
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	29/874	44/4579	1.11976781068432e-11	1.31255257809079e-10	6.7805799062599e-11	60/369/408/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	29
R-HSA-9649948	Signaling downstream of RAS mutants	29/874	44/4579	1.11976781068432e-11	1.31255257809079e-10	6.7805799062599e-11	60/369/408/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	29
R-HSA-5654719	SHC-mediated cascade:FGFR4	15/874	15/4579	1.47439943931885e-11	1.69332541667225e-10	8.74763303710705e-11	2246/8822/8817/2247/26281/8074/2253/2254/2264/2885/3265/3845/4893/6464/6654	15
R-HSA-5654720	PI-3K cascade:FGFR4	15/874	15/4579	1.47439943931885e-11	1.69332541667225e-10	8.74763303710705e-11	2246/8822/8817/2247/26281/8074/2253/2254/2264/10818/2549/2885/5290/5295/5781	15
R-HSA-170834	Signaling by TGF-beta Receptor Complex	38/874	69/4579	2.07225098496496e-11	2.35614936990515e-10	1.21717478906363e-10	867/1024/1025/1874/3065/3726/4609/9611/9612/23327/142/5494/5590/387/54778/5054/6497/6498/4087/4088/4089/4092/64750/6667/11171/10273/7027/7029/7040/7046/7048/7050/7314/7321/51377/25937/7514/9372	38
R-HSA-5655253	Signaling by FGFR2 in disease	26/874	38/4579	3.71675888788814e-11	4.18411371834537e-10	2.16149188060613e-10	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/10818/2549/2885/2962/3265/3845/4893/5290/5295/5335/5431/5432/5439/6654	26
R-HSA-5654688	SHC-mediated cascade:FGFR1	16/874	17/4579	3.88262550240775e-11	4.24475499638231e-10	2.192818856623e-10	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/2885/3265/3845/4893/6464/6654	16
R-HSA-5654689	PI-3K cascade:FGFR1	16/874	17/4579	3.88262550240775e-11	4.24475499638231e-10	2.192818856623e-10	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/10818/2549/2885/5290/5295/5781	16
R-HSA-5654712	FRS-mediated FGFR4 signaling	16/874	17/4579	3.88262550240775e-11	4.24475499638231e-10	2.192818856623e-10	2246/8822/8817/2247/26281/8074/2253/2254/2264/10818/2885/3265/3845/4893/5781/6654	16
R-HSA-8848021	Signaling by PTK6	31/874	51/4579	4.83214415975206e-11	5.18315840531896e-10	2.67759328812478e-10	207/2909/9564/867/595/898/1017/1019/1027/1398/1793/1796/1950/1956/2064/2065/2066/3091/3265/3845/2908/4893/3084/5753/5829/5879/5921/387/9021/6774/7314	31
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	31/874	51/4579	4.83214415975206e-11	5.18315840531896e-10	2.67759328812478e-10	207/2909/9564/867/595/898/1017/1019/1027/1398/1793/1796/1950/1956/2064/2065/2066/3091/3265/3845/2908/4893/3084/5753/5829/5879/5921/387/9021/6774/7314	31
R-HSA-8853659	RET signaling	25/874	36/4579	5.39782694036471e-11	5.73582171139689e-10	2.96309634306297e-10	1796/10818/2549/9846/2674/2887/2885/8660/5598/5290/5291/5293/5295/5296/8503/5335/5566/5567/5578/5781/5979/6464/53358/6654/6714	25
R-HSA-5654732	Negative regulation of FGFR3 signaling	21/874	27/4579	5.87766774137399e-11	6.18787798327984e-10	3.1966263154841e-10	673/867/2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/10818/2885/5594/5595/5515/5518/5781/6714/7314	21
R-HSA-5654693	FRS-mediated FGFR1 signaling	17/874	19/4579	6.03803340455455e-11	6.29838897337479e-10	3.25371573128096e-10	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/10818/2885/3265/3845/4893/5781/6654	17
R-HSA-6802952	Signaling by BRAF and RAF fusions	31/874	52/4579	9.81817816063361e-11	1.01484259714913e-09	5.24262527620436e-10	60/369/408/10018/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/8805/7529	31
R-HSA-5673000	RAF activation	23/874	32/4579	1.07617243483759e-10	1.10234960217148e-09	5.6946820164948e-10	369/673/801/805/808/815/816/817/818/3265/3717/3845/8844/5604/5605/4893/5515/5518/5519/5528/5894/6714/7529	23
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	27/874	42/4579	1.39312109119453e-10	1.41426667918587e-09	7.30602978276829e-10	1024/1025/1874/3065/3726/4609/9611/9612/23327/142/5494/54778/5054/6497/6498/4087/4088/4089/4092/64750/6667/7027/7029/7050/7314/7321/25937	27
R-HSA-114452	Activation of BH3-only proteins	22/874	30/4579	1.46519267611557e-10	1.47426909092336e-09	7.61599919210515e-10	207/208/10000/572/596/10018/1869/5599/5533/5534/2810/7027/7029/7157/8626/7161/7529/7531/7532/7533/10971/7534	22
R-HSA-5654726	Negative regulation of FGFR1 signaling	21/874	28/4579	1.93174430161992e-10	1.92666076398408e-09	9.95303158175359e-10	673/867/2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/10818/2885/5594/5595/5515/5518/5781/6714/7314	21
R-HSA-9018519	Estrogen-dependent gene expression	46/874	98/4579	2.26987247324517e-10	2.24421304528674e-09	1.15934905269639e-09	1386/8312/596/595/1025/4435/1387/6387/1655/2033/2066/2099/2288/2353/2354/3169/2625/2962/3014/3015/3020/3021/3065/3320/3326/3725/3727/8850/10524/4609/8648/10499/8202/8204/5431/5432/5439/5451/9126/6667/6908/7031/7033/7039/7391/7528	46
R-HSA-5654733	Negative regulation of FGFR4 signaling	20/874	26/4579	2.44501805073132e-10	2.39653924455302e-09	1.23803999302003e-09	673/867/2246/8822/8817/2247/26281/8074/2253/2254/2264/10818/2885/5594/5595/5515/5518/5781/6714/7314	20
R-HSA-112043	PLC beta mediated events	29/874	48/4579	2.54972953629492e-10	2.47781408783532e-09	1.28002616396992e-09	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/2770/2773/2775/2781/5594/5330/5331/5566/5567/5573/5577/5578/5580/5582/5613	29
R-HSA-2262752	Cellular responses to stress	110/874	334/4579	2.65388476223069e-10	2.5571754022511e-09	1.32102381563312e-09	64682/10393/51529/29882/29945/51433/367/405/472/545/815/816/817/818/847/8900/890/898/9134/8881/8697/246184/996/1017/1019/1021/1026/1027/1029/1051/1387/54205/3301/1869/2033/2113/2114/2146/2288/2353/51343/2932/3014/3015/3020/3021/10013/3091/3159/3281/3297/3320/3326/3303/3304/3312/3569/3725/10524/6416/5608/4217/9448/5594/5602/5600/1432/5595/5598/5599/5601/9261/8550/4193/4194/2475/653361/4790/2908/9972/8021/4928/5052/10935/5687/5688/5694/5717/5925/5928/9978/5970/6195/6196/6197/57521/23411/6648/6667/6774/7027/7029/7157/7295/7314/11065/7321/7422/7428/7531	110
R-HSA-1839124	FGFR1 mutant receptor activation	19/874	24/4579	2.93443440518552e-10	2.78037659891328e-09	1.43632841938028e-09	2246/8822/2247/26281/8074/2250/2253/2254/2260/9846/2885/9208/5290/5295/6772/6774/6776/6777/8805	19
R-HSA-9634638	Estrogen-dependent nuclear events downstream of ESR-membrane signaling	19/874	24/4579	2.93443440518552e-10	2.78037659891328e-09	1.43632841938028e-09	207/208/10000/374/596/595/1027/1385/1950/1956/2002/2353/2309/5594/5595/5747/6722/7039/7514	19
R-HSA-186797	Signaling by PDGF	30/874	51/4579	3.15818621170883e-10	2.96765101050656e-09	1.53307342856331e-09	9564/1398/1399/2885/3265/3845/4690/4893/5155/80310/5156/5159/5290/5291/5295/5296/5327/5335/5781/5782/2889/5921/6654/6696/6714/6772/6774/6776/6777/6778	30
R-HSA-2871809	FCERI mediated Ca+2 mobilization	22/874	31/4579	4.14589579328558e-10	3.8056515645583e-09	1.96598025554185e-09	695/801/805/808/2207/2885/27040/3937/4067/4772/4773/4775/5335/5530/5532/5534/6464/6654/6850/7409/7410/10451	22
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	13/874	13/4579	4.15040276169946e-10	3.8056515645583e-09	1.96598025554185e-09	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/5335	13
R-HSA-9027284	Erythropoietin activates RAS	13/874	13/4579	4.15040276169946e-10	3.8056515645583e-09	1.96598025554185e-09	1399/2057/2885/3265/8660/3717/3845/4067/4893/2889/6464/6654/7409	13
R-HSA-112040	G-protein mediated events	29/874	49/4579	5.12680903315932e-10	4.66334549656172e-09	2.40906058147613e-09	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/2770/2773/2775/2781/5594/5330/5331/5566/5567/5573/5577/5578/5580/5582/5613	29
R-HSA-438064	Post NMDA receptor activation events	35/874	66/4579	5.30650281257464e-10	4.78848706182331e-09	2.47370807804231e-09	107/801/805/808/8536/815/816/817/818/814/84254/10645/1385/2066/2903/3265/3845/5594/5595/4893/3084/5562/5563/5564/5566/5567/5573/5577/5613/5879/5923/6195/6196/6197/6714	35
R-HSA-8953897	Cellular responses to external stimuli	110/874	338/4579	5.93070974609909e-10	5.30961967032651e-09	2.74292253487219e-09	64682/10393/51529/29882/29945/51433/367/405/472/545/815/816/817/818/847/8900/890/898/9134/8881/8697/246184/996/1017/1019/1021/1026/1027/1029/1051/1387/54205/3301/1869/2033/2113/2114/2146/2288/2353/51343/2932/3014/3015/3020/3021/10013/3091/3159/3281/3297/3320/3326/3303/3304/3312/3569/3725/10524/6416/5608/4217/9448/5594/5602/5600/1432/5595/5598/5599/5601/9261/8550/4193/4194/2475/653361/4790/2908/9972/8021/4928/5052/10935/5687/5688/5694/5717/5925/5928/9978/5970/6195/6196/6197/57521/23411/6648/6667/6774/7027/7029/7157/7295/7314/11065/7321/7422/7428/7531	110
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	27/874	44/4579	6.52945509567046e-10	5.79999253420103e-09	2.9962466639672e-09	1024/1387/8454/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/3091/2648/8850/4609/9611/9612/4851/3516/9978/6500/79718/7314	27
R-HSA-111447	Activation of BAD and translocation to mitochondria 	14/874	15/4579	9.67531771604176e-10	8.39758491842709e-09	4.33814968706413e-09	207/208/10000/572/596/5533/5534/2810/7529/7531/7532/7533/10971/7534	14
R-HSA-5637810	Constitutive Signaling by EGFRvIII	14/874	15/4579	9.67531771604176e-10	8.39758491842709e-09	4.33814968706413e-09	867/1950/1956/2549/2885/3265/3320/3845/4893/5290/5295/5335/6464/6654	14
R-HSA-5637812	Signaling by EGFRvIII in Cancer	14/874	15/4579	9.67531771604176e-10	8.39758491842709e-09	4.33814968706413e-09	867/1950/1956/2549/2885/3265/3320/3845/4893/5290/5295/5335/6464/6654	14
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	19/874	25/4579	1.00528138782907e-09	8.65912831789132e-09	4.4732616778997e-09	466/1385/2002/5594/5600/1432/5595/5598/9261/4205/4208/5515/5518/5519/5528/6195/6196/6197/9252	19
R-HSA-6802957	Oncogenic MAPK signaling	31/874	56/4579	1.29255464685903e-09	1.1049884462246e-08	5.70831415075061e-09	60/369/408/10018/673/801/805/808/815/816/817/818/1445/2335/3265/3674/3690/3717/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/8805/7529	31
R-HSA-176412	Phosphorylation of the APC/C	15/874	17/4579	1.36017407108403e-09	1.15411784986757e-08	5.96211415290566e-09	64682/10393/51529/29882/29945/51433/891/8881/8697/246184/996/983/5347/11065/7321	15
R-HSA-388841	Costimulation by the CD28 family	34/874	65/4579	1.52287811496259e-09	1.28260179015738e-08	6.62585565808286e-09	207/208/10000/919/915/916/917/920/998/1445/1493/2534/2885/3122/3123/3932/4067/2475/5058/5062/5290/5295/5296/8503/5515/5518/5519/5528/5781/5777/5879/6714/7409/7525	34
R-HSA-202733	Cell surface interactions at the vascular wall	43/874	93/4579	1.61243190875945e-09	1.3480405001908e-08	6.96390870810969e-09	857/914/960/1278/2207/2335/2534/2885/3265/3635/3675/3676/3678/3655/3684/3685/3688/3689/3690/3845/3932/4067/4282/4312/4893/5290/5291/5295/5296/5335/10544/5781/5777/6382/6383/6385/6402/6464/6654/6714/7010/7040/7525	43
R-HSA-111996	Ca-dependent events	23/874	35/4579	1.77404532913472e-09	1.47232813082203e-08	7.6059722908734e-09	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/5594/5566/5567/5573/5577/5578/5580/5582/5613	23
R-HSA-2033519	Activated point mutants of FGFR2	12/874	12/4579	2.19894308731803e-09	1.81173789150768e-08	9.35934586364196e-09	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263	12
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	20/874	28/4579	2.23007151894491e-09	1.82416641513695e-08	9.42355098501523e-09	324/8312/857/1452/1455/1499/1855/1856/1857/10023/8321/2535/7855/2932/4040/5515/5518/5519/5528/89780	20
R-HSA-8878166	Transcriptional regulation by RUNX2	47/874	107/4579	2.29402872897631e-09	1.86307904631862e-08	9.62457165991566e-09	25/207/208/10000/367/650/891/595/983/1019/1026/8454/2099/55294/2736/2737/2932/8841/9759/10013/3280/3678/3958/5594/5595/4322/2908/5687/5688/5694/5717/5925/9978/860/6500/4086/4089/4091/6662/6714/6772/10273/7314/11059/25937/10413/7525	47
R-HSA-442755	Activation of NMDA receptors and postsynaptic events	35/874	69/4579	2.56603464646066e-09	2.06847613320117e-08	1.06856425711823e-08	107/801/805/808/8536/815/816/817/818/814/84254/10645/1385/2066/2903/3265/3845/5594/5595/4893/3084/5562/5563/5564/5566/5567/5573/5577/5613/5879/5923/6195/6196/6197/6714	35
R-HSA-1489509	DAG and IP3 signaling	24/874	38/4579	2.5833211162231e-09	2.06847613320117e-08	1.06856425711823e-08	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/5335/5566/5567/5573/5577/5578/5580/5581/5582/5613	24
R-HSA-111933	Calmodulin induced events	22/874	33/4579	2.68642790403664e-09	2.12115869922893e-08	1.09577980296232e-08	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/5566/5567/5573/5577/5578/5580/5582/5613	22
R-HSA-111997	CaM pathway	22/874	33/4579	2.68642790403664e-09	2.12115869922893e-08	1.09577980296232e-08	107/108/113/801/805/808/815/816/817/818/814/84254/10645/1385/5566/5567/5573/5577/5578/5580/5582/5613	22
R-HSA-5633007	Regulation of TP53 Activity	53/874	128/4579	2.84378048006207e-09	2.22991614195212e-08	1.15196334509955e-08	207/208/10000/472/545/6790/9212/580/641/672/8900/890/983/1017/1020/1029/1111/11200/1457/1616/8445/2033/3065/3066/10524/5608/5600/1432/8550/4193/4194/2475/5300/1263/5371/10848/5515/5518/5519/639/5562/5563/5564/5928/6794/6872/6881/6908/11073/7157/8626/7161/7314	53
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	30/874	55/4579	3.86235403390936e-09	2.9276643577033e-08	1.5124165269624e-08	6868/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/182/2648/8850/4609/9611/9612/4851/5663/3516/9978/6500/79718/7314	30
R-HSA-2644603	Signaling by NOTCH1 in Cancer	30/874	55/4579	3.86235403390936e-09	2.9276643577033e-08	1.5124165269624e-08	6868/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/182/2648/8850/4609/9611/9612/4851/5663/3516/9978/6500/79718/7314	30
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	30/874	55/4579	3.86235403390936e-09	2.9276643577033e-08	1.5124165269624e-08	6868/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/182/2648/8850/4609/9611/9612/4851/5663/3516/9978/6500/79718/7314	30
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	30/874	55/4579	3.86235403390936e-09	2.9276643577033e-08	1.5124165269624e-08	6868/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/182/2648/8850/4609/9611/9612/4851/5663/3516/9978/6500/79718/7314	30
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	30/874	55/4579	3.86235403390936e-09	2.9276643577033e-08	1.5124165269624e-08	6868/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/182/2648/8850/4609/9611/9612/4851/5663/3516/9978/6500/79718/7314	30
R-HSA-9006115	Signaling by NTRK2 (TRKB)	18/874	24/4579	4.08131943350851e-09	3.05293433940735e-08	1.57713036281007e-08	627/1020/10818/2534/2549/2885/3265/3845/4893/4915/5290/5295/5335/5781/5879/6464/6654/6714	18
R-HSA-9022692	Regulation of MECP2 expression and activity	18/874	24/4579	4.08131943350851e-09	3.05293433940735e-08	1.57713036281007e-08	9212/801/805/808/815/816/817/818/814/1385/3065/3066/8841/9611/9612/5566/25942/79718	18
R-HSA-1980143	Signaling by NOTCH1	34/874	67/4579	4.29315437186571e-09	3.19040295477863e-08	1.64814595080913e-08	6868/408/1024/1387/8454/28514/2033/55294/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/3091/83737/182/2648/8850/4609/9611/9612/4851/8650/5663/3516/9978/6500/79718/7314	34
R-HSA-912631	Regulation of signaling by CBL	17/874	22/4579	5.18029542837997e-09	3.82467266368054e-08	1.97580645867124e-08	867/1398/1399/2534/2885/4067/5290/5291/5293/5295/5296/8503/2889/6850/7314/7409/7525	17
R-HSA-5218921	VEGFR2 mediated cell proliferation	16/874	20/4579	6.17336739277816e-09	4.52846369392824e-08	2.33938132778962e-08	801/805/808/3265/3791/3845/4893/5335/5578/5579/5580/5590/5921/8877/6714/7422	16
R-HSA-8986944	Transcriptional Regulation by MECP2	25/874	42/4579	7.01190523551976e-09	5.11060016204228e-08	2.64011006843456e-08	9212/627/801/805/808/815/816/817/818/814/1385/28514/2903/3065/3066/8841/4208/4233/9611/9612/5468/5566/5728/25942/79718	25
R-HSA-8941326	RUNX2 regulates bone development	19/874	27/4579	8.52113963693198e-09	6.171041889931e-08	3.18792887523168e-08	25/367/2736/2737/8841/9759/10013/3280/5594/5595/5925/860/4086/4089/4091/6714/25937/10413/7525	19
R-HSA-1280218	Adaptive Immune System	139/874	476/4579	1.05808436491663e-08	7.61418938550765e-08	3.93345153646555e-08	207/208/10000/64682/10393/51529/29882/29945/51433/1173/375/567/640/695/8945/801/805/808/868/919/915/916/917/920/958/925/8881/991/8697/246184/996/998/999/1147/1278/1445/1493/8454/55294/2214/2534/51343/2885/3105/3122/3123/3133/3265/3383/3551/8517/3635/83737/3676/3685/3688/3689/3693/3695/22914/100528032/3845/27040/3932/3937/4067/6885/2475/653361/4690/23327/4772/4773/4775/4790/4792/4893/55824/5058/5062/5290/5291/5293/5295/5296/8503/5335/5515/5518/5519/5528/5530/5532/5534/5566/5567/5579/5588/5687/5688/5694/5717/5728/5781/5777/5795/5879/5894/5906/5908/10235/9978/25898/5970/54778/9604/6402/6477/6500/64750/8651/9021/6654/6714/10273/6850/23118/7099/7189/7314/11065/7321/7408/7409/7428/11059/7525/7529/7534	139
R-HSA-210990	PECAM1 interactions	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	2534/3635/3685/3690/3932/4067/5335/5781/5777/6714/7525	11
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261/5335	11
R-HSA-5655291	Signaling by FGFR4 in disease	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	2264/10818/2549/2885/3265/3845/4893/5290/5295/5335/6654	11
R-HSA-9020558	Interleukin-2 signaling	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	3559/3560/3561/3716/3718/3932/2185/6464/6776/6777/6850	11
R-HSA-9027276	Erythropoietin activates Phosphoinositide-3-kinase (PI3K)	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	2057/2549/8660/3717/4067/5290/5291/5293/5294/5295/23533	11
R-HSA-9614399	Regulation of localization of FOXO transcription factors	11/874	11/4579	1.16393650322929e-08	8.06948661080308e-08	4.16865576894702e-08	207/208/10000/2308/2309/4303/2810/7529/7532/10971/7534	11
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	18/874	25/4579	1.19911315509699e-08	8.26297974148656e-08	4.26861333680461e-08	207/208/10000/572/842/1026/1027/1147/1385/2308/2309/4303/2931/2932/4193/2475/3164/6199	18
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	36/874	76/4579	1.60055061219365e-08	1.09628075064108e-07	5.66333063794584e-08	25/60/695/919/917/998/1398/1793/2214/2268/2534/2885/3320/3326/4067/5594/5595/4690/4771/5058/5290/5291/5295/5296/5335/5337/5580/5581/5747/5879/6714/6850/7409/7410/10451/7525	36
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	23/874	38/4579	1.82347155716687e-08	1.24148931766391e-07	6.41347071477537e-08	1820/6790/8900/890/891/898/9134/983/1017/1026/1027/1869/1874/2033/1647/4869/5111/1263/5934/2810/7027/7029/7157	23
R-HSA-195721	Signaling by WNT	83/874	247/4579	1.84485900581752e-08	1.24857422000864e-07	6.45007096018907e-08	207/208/1173/324/8312/8945/801/805/808/815/857/1387/1452/1455/1457/1487/1499/8454/23002/1855/1856/1857/2033/10023/8321/2535/8322/7855/8323/8325/2775/2782/2783/10681/54331/2932/3014/3015/3020/3021/3065/10524/3845/51176/4040/6885/4609/4772/51701/5330/5331/5515/5518/5519/5528/5530/5532/5534/5578/5579/5582/5687/5688/5694/5717/5879/5880/9978/387/4919/4920/6259/6422/6500/64750/6662/6932/83439/6934/7314/89780/7514/7534	83
R-HSA-1250196	SHC1 events in ERBB2 signaling	16/874	21/4579	2.134997095934e-08	1.4195857883491e-07	7.333508030355e-08	1950/1956/2064/2065/2066/2885/3265/3845/4893/3084/5578/5580/5581/5782/6464/6654	16
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	16/874	21/4579	2.134997095934e-08	1.4195857883491e-07	7.333508030355e-08	64682/10393/51529/29882/29945/51433/891/8881/991/8697/246184/996/983/7314/11065/7321	16
R-HSA-445144	Signal transduction by L1	16/874	21/4579	2.134997095934e-08	1.4195857883491e-07	7.333508030355e-08	1457/1956/2260/3674/3678/3680/3685/3688/3690/5604/5605/5594/5595/5058/5879/7410	16
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	21/874	33/4579	2.1699366918635e-08	1.43442908060977e-07	7.4101877237444e-08	60/369/408/673/1445/2335/3265/3674/3690/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	21
R-HSA-190241	FGFR2 ligand binding and activation	12/874	13/4579	2.36057768210951e-08	1.54251541641294e-07	7.96855624087783e-08	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263	12
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	12/874	13/4579	2.36057768210951e-08	1.54251541641294e-07	7.96855624087783e-08	891/983/1111/11200/2810/7465/7529/7531/7532/7533/10971/7534	12
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	15/874	19/4579	2.63101938363042e-08	1.69969831772033e-07	8.7805551200106e-08	867/1950/1956/2549/2885/3265/3320/3845/4893/5290/5295/5335/6464/6654/7314	15
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	15/874	19/4579	2.63101938363042e-08	1.69969831772033e-07	8.7805551200106e-08	867/1950/1956/2549/2885/3265/3320/3845/4893/5290/5295/5335/6464/6654/7314	15
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	14/874	17/4579	2.98075633900958e-08	1.91475703810954e-07	9.89153753890778e-08	64682/10393/51529/29882/29945/51433/8881/991/8697/246184/996/51343/11065/7321	14
R-HSA-4086398	Ca2+ pathway	28/874	53/4579	3.29232820332631e-08	2.10302088043933e-07	1.08640989796338e-07	801/805/808/815/1499/2535/8322/7855/8323/2775/2782/2783/10681/54331/3845/51176/6885/4772/51701/5330/5331/5530/5532/5534/5578/6932/83439/6934	28
R-HSA-1538133	G0 and Early G1	17/874	24/4579	4.61223861721747e-08	2.92967335629958e-07	1.51345436542625e-07	8900/890/898/9134/993/983/1017/1869/1874/3065/4149/4609/5111/5928/5934/7027/7029	17
R-HSA-6806834	Signaling by MET	33/874	69/4579	4.77899418306697e-08	3.0187313256373e-07	1.55946125973764e-07	382/867/1278/1398/1399/2335/2549/2885/3082/9146/3265/3673/3675/3688/3845/284217/4233/4893/5290/5295/5747/5781/5771/5795/5879/5906/5908/2889/6464/6654/6714/6774/7314	33
R-HSA-1236394	Signaling by ERBB4	26/874	48/4579	5.23300651219728e-08	3.27514218276645e-07	1.69192180528971e-07	6868/6387/1950/1956/2065/2066/2099/2885/3265/83737/3845/9611/4893/3084/5290/5295/5663/6464/6654/6714/6776/3925/23118/7314/11059/10413	26
R-HSA-1640170	Cell Cycle	127/874	435/4579	5.2425319020536e-08	3.27514218276645e-07	1.69192180528971e-07	25/207/208/10000/64682/10393/51529/29882/29945/51433/472/545/6790/9212/580/641/672/675/8945/8900/890/891/595/894/896/898/9134/902/8881/991/8697/993/246184/996/983/1017/1019/1021/1022/1026/1027/1028/1029/1111/11200/1163/1457/8454/1869/1874/2033/2305/51343/2932/3014/3015/3020/3021/3065/55869/3320/3326/3619/3717/10524/4067/5594/5595/4149/79648/9656/4193/4194/4609/4751/10783/4869/9972/8021/4928/4998/5111/51588/5347/10714/5515/5518/5519/5520/5528/5566/5577/5578/5579/5687/5688/5694/5717/5753/9232/5905/5925/5928/5934/9978/2810/6500/9126/6714/7341/7027/7029/11073/7157/203068/7314/11065/7321/7329/7465/7514/7529/7531/7532/7533/10971/7534	127
R-HSA-112314	Neurotransmitter receptors and postsynaptic signal transmission	50/874	127/4579	5.84819248351115e-08	3.63354910041103e-07	1.87707299729607e-07	107/108/113/1173/801/805/808/8536/815/816/817/818/814/84254/10645/1385/2066/2770/2773/2782/2783/10681/54331/2903/3265/3845/5594/5595/4193/4893/3084/5330/5331/5562/5563/5564/5566/5567/5573/5577/5578/5579/5582/5613/5879/5923/6195/6196/6197/6714	50
R-HSA-170968	Frs2-mediated activation	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	673/1399/10818/5604/5605/5594/5595/5906/2889/7529	10
R-HSA-1839130	Signaling by activated point mutants of FGFR3	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261	10
R-HSA-190239	FGFR3 ligand binding and activation	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261	10
R-HSA-190372	FGFR3c ligand binding and activation	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261	10
R-HSA-190375	FGFR2c ligand binding and activation	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2250/2253/2254/2263	10
R-HSA-2033514	FGFR3 mutant receptor activation	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2250/2253/2254/2261	10
R-HSA-450341	Activation of the AP-1 family of transcription factors	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	1386/2353/3725/5594/5602/5600/1432/5595/5599/5601	10
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2246/8822/8817/2247/26281/8074/2253/2254/2264/5335	10
R-HSA-8853334	Signaling by FGFR3 fusions in cancer	10/874	10/4579	6.15512255006324e-08	3.64498663511557e-07	1.88298156959171e-07	2261/10818/2549/2885/3265/3845/4893/5290/5295/6654	10
R-HSA-198753	ERK/MAPK targets	16/874	22/4579	6.44691057085666e-08	3.77842129848661e-07	1.95191323849051e-07	2002/5594/5600/1432/5595/5598/4205/4208/5515/5518/5519/5528/6195/6196/6197/9252	16
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	16/874	22/4579	6.44691057085666e-08	3.77842129848661e-07	1.95191323849051e-07	3065/9611/9612/23327/142/5494/54778/6497/6498/4087/4088/4089/64750/7050/7314/7321	16
R-HSA-69242	S Phase	53/874	139/4579	8.23155036777912e-08	4.79962706059737e-07	2.47946294478853e-07	207/208/10000/64682/10393/51529/29882/29945/51433/8900/890/595/898/9134/902/8881/8697/993/246184/996/1017/1019/1022/1026/1027/1163/8454/1869/1874/51343/2932/4149/4609/4998/5111/10714/5687/5688/5694/5717/5753/5925/5928/5934/9978/6500/9126/7027/7029/7314/11065/7321/7465	53
R-HSA-5357801	Programmed Cell Death	60/874	165/4579	8.48515252174217e-08	4.92225429450043e-07	2.54281155055431e-07	207/208/10000/317/324/572/596/598/10018/660/836/839/840/841/842/999/1029/1499/54205/1612/1613/1869/8772/355/356/2934/3837/5594/5595/5599/5062/5533/5534/5580/5588/5687/5688/5694/5717/5747/8737/11035/2810/6774/8428/7027/7029/148022/7099/7157/8626/7161/7186/7314/7529/7531/7532/7533/10971/7534	60
R-HSA-5621575	CD209 (DC-SIGN) signaling	15/874	20/4579	8.67206731668821e-08	4.97986895912853e-07	2.57257499346732e-07	1387/2033/2534/3265/3845/4067/4790/4893/5058/5062/5566/5567/5894/5970/9252	15
R-HSA-982772	Growth hormone receptor signaling	15/874	20/4579	8.67206731668821e-08	4.97986895912853e-07	2.57257499346732e-07	6868/3667/8660/3717/4067/5594/5595/5777/8651/8835/9021/6772/6774/6776/6777	15
R-HSA-5674135	MAP2K and MAPK activation	21/874	35/4579	9.58710039077391e-08	5.4776548463869e-07	2.82972865276479e-07	60/369/408/673/1445/2335/3265/3674/3690/3845/8844/5604/5605/5594/5595/4893/5894/5906/5908/6714/7529	21
R-HSA-109581	Apoptosis	59/874	162/4579	1.02537184021803e-07	5.82923891163948e-07	3.01135519390347e-07	207/208/10000/317/324/572/596/598/10018/660/836/839/840/841/842/999/1029/1499/54205/1612/1613/1869/8772/355/356/2934/3837/5594/5595/5599/5062/5533/5534/5580/5588/5687/5688/5694/5717/5747/8737/2810/6774/8428/7027/7029/148022/7099/7157/8626/7161/7186/7314/7529/7531/7532/7533/10971/7534	59
R-HSA-167044	Signalling to RAS	14/874	18/4579	1.10603885925483e-07	6.22557516323139e-07	3.21610048704635e-07	2885/3265/3845/5600/6300/5603/1432/9261/4893/6464/25759/53358/6654/6714	14
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	14/874	18/4579	1.10603885925483e-07	6.22557516323139e-07	3.21610048704635e-07	1385/1956/2885/3265/3845/5594/5595/5598/4893/5578/6195/6196/6197/6654	14
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	11/874	12/4579	1.15484006427017e-07	6.3432519472231e-07	3.27689171554922e-07	801/805/808/815/816/817/818/814/84254/10645/1385	11
R-HSA-169893	Prolonged ERK activation events	11/874	12/4579	1.15484006427017e-07	6.3432519472231e-07	3.27689171554922e-07	673/1398/1399/10818/5604/5605/5594/5595/5906/2889/7529	11
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	11/874	12/4579	1.15484006427017e-07	6.3432519472231e-07	3.27689171554922e-07	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260/5335	11
R-HSA-9005891	Loss of function of MECP2 in Rett syndrome	11/874	12/4579	1.15484006427017e-07	6.3432519472231e-07	3.27689171554922e-07	801/805/808/814/3065/8841/9611/9612/5566/25942/79718	11
R-HSA-9005895	Pervasive developmental disorders	11/874	12/4579	1.15484006427017e-07	6.3432519472231e-07	3.27689171554922e-07	801/805/808/814/3065/8841/9611/9612/5566/25942/79718	11
R-HSA-1643713	Signaling by EGFR in Cancer	17/874	25/4579	1.18651302242234e-07	6.45485792580959e-07	3.3345467968354e-07	374/867/1950/1956/2549/2885/3265/3320/3845/4893/5290/5295/5335/6464/6654/7039/7314	17
R-HSA-442742	CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling	17/874	25/4579	1.18651302242234e-07	6.45485792580959e-07	3.3345467968354e-07	801/805/808/815/816/817/818/1385/3265/3845/5594/5595/4893/5923/6195/6196/6197	17
R-HSA-5621481	C-type lectin receptors (CLRs)	47/874	119/4579	1.31634250393434e-07	7.12705441415879e-07	3.68180008619229e-07	8945/801/805/808/841/1147/1387/8454/2033/2207/2534/3265/3551/8517/3553/3845/4067/6885/4772/4773/4775/4790/4792/4893/5058/5062/5530/5532/5534/5566/5567/5580/5687/5688/5694/5717/5894/5970/9252/6500/6714/6850/10454/23118/7189/7314/7321	47
R-HSA-877312	Regulation of IFNG signaling	12/874	14/4579	1.36481582553556e-07	7.31979053600911e-07	3.78136658713427e-07	3458/3459/3716/3717/8554/5781/5771/5777/8651/9021/6772/7341	12
R-HSA-8849471	PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases	12/874	14/4579	1.36481582553556e-07	7.31979053600911e-07	3.78136658713427e-07	2909/9564/1398/1793/3265/3845/4893/5753/5829/5879/5921/387	12
R-HSA-877300	Interferon gamma signaling	30/874	62/4579	1.41631253896819e-07	7.56031622914005e-07	3.90562093770323e-07	567/815/816/817/818/960/4261/3105/3122/3123/3133/3383/3458/3459/3661/10379/3716/3717/8554/5371/5580/5724/5781/5771/5777/8651/9021/6672/6772/7341	30
R-HSA-177929	Signaling by EGFR	25/874	47/4579	1.52638008273902e-07	8.1097857667022e-07	4.1894741080589e-07	6868/374/867/998/1445/1950/1956/2549/2885/9146/3265/3845/4893/55824/5290/5295/5335/5781/5782/5829/6464/6654/6714/7039/7314	25
R-HSA-453279	Mitotic G1-G1/S phases	52/874	138/4579	1.71407095275246e-07	9.06464499199788e-07	4.68274953065298e-07	25/207/208/10000/8900/890/891/595/894/896/898/9134/902/993/983/1017/1019/1021/1022/1026/1027/1028/1029/1163/8454/1869/1874/3065/3717/4067/4149/4609/4998/5111/5515/5518/5519/5520/5687/5688/5694/5717/5753/5925/5928/5934/6500/6714/7027/7029/7314/7465	52
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	16/874	23/4579	1.74470953654351e-07	9.18395714374986e-07	4.74438558182884e-07	8900/890/891/902/993/983/1017/1022/2305/5347/5515/5518/5519/5520/7465/7514	16
R-HSA-4090294	SUMOylation of intracellular receptors	18/874	28/4579	1.82367588354482e-07	9.55538930686849e-07	4.93626554944463e-07	367/2099/9759/2908/2516/8554/9063/10401/51588/5465/5468/5914/6256/7341/6613/7067/7329/7421	18
R-HSA-157118	Signaling by NOTCH	61/874	172/4579	1.87000638408999e-07	9.75319843445098e-07	5.03845273936365e-07	6868/207/408/595/1024/1385/1387/8454/28514/1869/1950/1956/2033/55294/2324/3014/3015/3020/3021/3065/3066/8841/9759/10014/10013/51564/55869/9734/3280/3091/83737/182/3725/2648/8850/3955/4242/4609/9611/9612/4851/8650/23509/5584/5663/5687/5688/5694/5717/3516/9978/6500/4088/6772/79718/7027/7029/7157/7314/4904/7534	61
R-HSA-8878159	Transcriptional regulation by RUNX3	39/874	93/4579	2.48421946619929e-07	1.28975229820483e-06	6.66279481922231e-07	10018/1490/595/1026/1029/1387/1499/2033/2309/9759/3280/3676/182/2648/8850/3845/51176/4193/4609/4851/5687/5688/5694/5717/3516/4088/4089/64750/6696/6714/6932/83439/6934/7003/7040/7157/7314/25937/10413	39
R-HSA-2559580	Oxidative Stress Induced Senescence	32/874	70/4579	2.86100454460873e-07	1.47861916691824e-06	7.63847146359652e-07	1019/1021/1029/1869/2146/2353/3014/3015/3020/3021/3725/6416/5608/4217/9448/5594/5602/5600/1432/5595/5599/5601/9261/8550/4193/4194/5928/7027/7029/7157/7295/7314	32
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	35/874	80/4579	3.00642888863222e-07	1.54674644632345e-06	7.99041352634807e-07	207/208/10000/8900/890/595/898/9134/902/993/1017/1019/1022/1026/1027/1163/8454/1869/1874/51343/4149/4609/5687/5688/5694/5717/5753/5925/5928/5934/6500/7027/7029/7314/7465	35
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	33/874	74/4579	3.82411066516804e-07	1.95856478661985e-06	1.01178461411274e-06	472/545/6790/9212/580/641/672/8900/890/1017/1020/1111/11200/1457/8445/10524/5600/1432/8550/4193/4194/5300/1263/5562/5563/5564/6794/6872/6881/6908/11073/7157/7314	33
R-HSA-3858494	Beta-catenin independent WNT signaling	49/874	130/4579	3.88289039103155e-07	1.97975173749008e-06	1.02272968524692e-06	1173/801/805/808/815/1499/23002/1855/1856/1857/8321/2535/8322/7855/8323/8325/2775/2782/2783/10681/54331/3845/51176/6885/4772/51701/5330/5331/5530/5532/5534/5578/5579/5582/5687/5688/5694/5717/5879/5880/387/4919/4920/6259/64750/6932/83439/6934/7314	49
R-HSA-5218920	VEGFR2 mediated vascular permeability	18/874	29/4579	3.95691302018966e-07	2.00848665355163e-06	1.03757399683545e-06	207/208/10000/801/805/808/857/1495/1499/1500/3320/2475/5058/5062/5879/7409/7410/10451	18
R-HSA-3000170	Syndecan interactions	16/874	24/4579	4.31168088618702e-07	2.15016717876958e-06	1.11076543605372e-06	1278/2247/2335/3673/3655/3685/3688/3690/3691/3693/5578/6382/6383/6385/7040/3371	16
R-HSA-3371571	HSF1-dependent transactivation	16/874	24/4579	4.31168088618702e-07	2.15016717876958e-06	1.11076543605372e-06	815/816/817/818/1387/2033/2288/3281/3297/3320/3326/3303/3304/3312/2475/57521	16
R-HSA-354192	Integrin alphaIIb beta3 signaling	16/874	24/4579	4.31168088618702e-07	2.15016717876958e-06	1.11076543605372e-06	207/9564/1398/1445/2335/2885/3674/3690/5747/5906/5908/10235/6464/6654/6714/6850	16
R-HSA-9006921	Integrin signaling	16/874	24/4579	4.31168088618702e-07	2.15016717876958e-06	1.11076543605372e-06	207/9564/1398/1445/2335/2885/3674/3690/5747/5906/5908/10235/6464/6654/6714/6850	16
R-HSA-180292	GAB1 signalosome	13/874	17/4579	4.57906080703028e-07	2.27353368453862e-06	1.17449594590802e-06	374/1445/1950/1956/2549/2885/55824/5290/5295/5781/5829/6714/7039	13
R-HSA-202403	TCR signaling	43/874	109/4579	4.73188071719567e-07	2.33919494584847e-06	1.20841621976896e-06	8945/919/915/916/917/920/1147/1445/8454/3122/3123/3551/8517/3635/27040/3932/3937/6885/4690/4790/4792/55824/5058/5062/5290/5291/5295/5296/5335/5588/5687/5688/5694/5717/5728/5795/5970/6500/23118/7189/7314/7321/7408	43
R-HSA-69202	Cyclin E associated events during G1/S transition 	34/874	78/4579	4.94632073247624e-07	2.43461760728376e-06	1.2577110816686e-06	207/208/10000/8900/890/595/898/9134/902/993/1017/1019/1022/1026/1027/1163/8454/1869/1874/4149/4609/5687/5688/5694/5717/5753/5925/5928/5934/6500/7027/7029/7314/7465	34
R-HSA-389356	CD28 co-stimulation	19/874	32/4579	5.02097008882908e-07	2.46070818577529e-06	1.27118934190863e-06	207/208/10000/998/2534/2885/3932/4067/2475/5058/5062/5290/5295/5296/8503/5879/6714/7409/7525	19
R-HSA-1059683	Interleukin-6 signaling	10/874	11/4579	5.60669830184027e-07	2.71268764646485e-06	1.40136065058314e-06	867/3569/3572/3716/3717/5781/9021/6772/6774/7297	10
R-HSA-190242	FGFR1 ligand binding and activation	10/874	11/4579	5.60669830184027e-07	2.71268764646485e-06	1.40136065058314e-06	2246/8822/2247/26281/27006/8074/2250/2253/2254/2260	10
R-HSA-8875555	MET activates RAP1 and RAC1	10/874	11/4579	5.60669830184027e-07	2.71268764646485e-06	1.40136065058314e-06	1398/1399/2549/2885/3082/4233/5879/5906/5908/2889	10
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	12/874	15/4579	5.63769462858941e-07	2.71612660707888e-06	1.4031372001574e-06	2207/2534/9846/2885/4067/5290/5291/5295/5296/6464/6654/6850	12
R-HSA-6806003	Regulation of TP53 Expression and Degradation	20/874	35/4579	5.92253798570494e-07	2.84131885643313e-06	1.46781087986825e-06	207/208/10000/472/8900/890/983/1017/1029/11200/1616/4193/4194/2475/5515/5518/5519/639/7157/7314	20
R-HSA-198323	AKT phosphorylates targets in the cytosol	11/874	13/4579	6.20814269259586e-07	2.96582279053844e-06	1.53212897941994e-06	207/208/10000/572/842/1026/1027/1147/2931/2932/4193	11
R-HSA-350054	Notch-HLH transcription pathway	17/874	27/4579	6.27408363056838e-07	2.98478371881014e-06	1.54192409859377e-06	1387/3065/3066/8841/9759/10014/10013/51564/55869/9734/2648/8850/9611/9612/4851/3516/79718	17
R-HSA-9615017	FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	15/874	22/4579	6.48029549351102e-07	3.07003999005085e-06	1.58596705499085e-06	847/2308/2309/4303/2645/3065/3066/2908/5443/25942/4087/4088/4089/6648/6720	15
R-HSA-1474244	Extracellular matrix organization	60/874	174/4579	7.19738504019147e-07	3.39561277622311e-06	1.75415630156228e-06	6868/8754/351/54829/650/652/655/823/824/836/960/999/1278/780/4921/2200/2247/2335/3383/3672/8515/3673/3674/3675/3676/3678/3655/3679/8516/3680/3684/3685/3688/3689/3690/3691/3693/3694/3695/3696/3791/284217/4052/4312/4322/4323/4313/4318/5155/5578/5663/6382/6383/6385/5054/6696/7040/7042/7043/3371	60
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	18/874	30/4579	8.14235553850862e-07	3.82556125920839e-06	1.97626550260453e-06	1024/1025/1874/3065/3726/4609/54778/5054/4087/4088/4089/4092/6667/7027/7029/7050/7314/25937	18
R-HSA-180024	DARPP-32 events	16/874	25/4579	9.86753486621317e-07	4.59810948478868e-06	2.37535998936452e-06	801/805/808/1020/5515/5518/5519/5528/5530/5532/5533/5534/5566/5567/5573/5577	16
R-HSA-2129379	Molecules associated with elastic fibres	16/874	25/4579	9.86753486621317e-07	4.59810948478868e-06	2.37535998936452e-06	650/652/655/2200/2335/8516/3685/3688/3690/3693/3694/3696/4052/7040/7042/7043	16
R-HSA-388396	GPCR downstream signalling	120/874	426/4579	1.08742177321194e-06	5.04652471894684e-06	2.60700902020306e-06	107/108/113/133/154/207/208/10000/301/351/408/695/801/805/808/815/816/817/818/814/84254/10645/1230/2826/1232/1233/1234/1235/1236/10803/998/1020/1385/1524/2919/6387/2921/6374/3577/3579/2833/7852/643/10663/1906/1956/2149/2150/2767/2768/10672/9630/2769/2770/2773/2775/2776/2781/2782/2783/10681/54331/2719/2885/3265/3845/23566/4023/5594/5595/5598/25791/4893/5058/5290/5294/5295/5296/8503/23533/5330/5331/5443/5515/5518/5519/5528/5530/5532/5533/5534/5566/5567/5573/5577/5578/5579/5580/5581/5582/5588/5613/5724/10235/387/388/6195/6196/6197/6288/6382/6383/6385/6654/6714/6915/7409/7410/10451/2829	120
R-HSA-1566948	Elastic fibre formation	17/874	28/4579	1.3151986512332e-06	6.0787840099681e-06	3.14026892335528e-06	650/652/655/2200/2335/3678/8516/3685/3688/3690/3693/3694/3696/4052/7040/7042/7043	17
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	13/874	18/4579	1.36089178712465e-06	6.21419261831617e-06	3.21022032219638e-06	64682/10393/51529/29882/29945/51433/8881/991/8697/246184/996/11065/7321	13
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	13/874	18/4579	1.36089178712465e-06	6.21419261831617e-06	3.21022032219638e-06	64682/10393/51529/29882/29945/51433/8881/991/8697/246184/996/11065/7321	13
R-HSA-3232118	SUMOylation of transcription factors	13/874	18/4579	1.36089178712465e-06	6.21419261831617e-06	3.21022032219638e-06	1029/4193/4286/9112/8554/9063/10401/51588/7341/6613/7020/7157/7329	13
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	15/874	23/4579	1.53595191628251e-06	6.98550931525285e-06	3.60867860751849e-06	64682/10393/51529/29882/29945/51433/8881/991/8697/246184/996/4751/7314/11065/7321	15
R-HSA-372790	Signaling by GPCR	129/874	469/4579	1.68345788080043e-06	7.62586298992069e-06	3.93948206117275e-06	107/108/113/133/154/207/208/10000/301/351/408/695/801/805/808/815/816/817/818/814/84254/10645/6347/1230/2826/1232/1233/1234/1235/1236/10803/998/1020/1385/1524/2919/6387/2921/6374/3577/3579/2833/7852/643/10663/1906/1956/2149/2150/8321/2535/8322/7855/8323/8325/2767/2768/10672/9630/2769/2770/2773/2775/2776/2781/2782/2783/10681/54331/2719/2885/3265/3845/23566/4023/5594/5595/5598/25791/4893/5058/5290/5294/5295/5296/8503/23533/5330/5331/5443/5515/5518/5519/5528/5530/5532/5533/5534/5566/5567/5573/5577/5578/5579/5580/5581/5582/5588/5613/5724/10235/387/388/6195/6196/6197/6288/6382/6383/6385/6608/6654/6714/6915/7409/7410/10451/89780/2829	129
R-HSA-6804757	Regulation of TP53 Degradation	19/874	34/4579	1.81641587864104e-06	8.19549545243992e-06	4.23375129608061e-06	207/208/10000/472/8900/890/983/1017/1029/11200/1616/4193/4194/2475/5515/5518/5519/7157/7314	19
R-HSA-1433559	Regulation of KIT signaling	12/874	16/4579	1.86346797257399e-06	8.30887484241815e-06	4.29232251267817e-06	867/2534/2885/3815/3932/4067/5578/5777/8651/6654/6714/7525	12
R-HSA-9034015	Signaling by NTRK3 (TRKC)	12/874	16/4579	1.86346797257399e-06	8.30887484241815e-06	4.29232251267817e-06	2885/3265/3667/3845/25920/4893/5290/5295/5335/6464/6654/6714	12
R-HSA-9617828	FOXO-mediated transcription of cell cycle genes	12/874	16/4579	1.86346797257399e-06	8.30887484241815e-06	4.29232251267817e-06	857/1026/1027/2308/2309/4303/1647/9314/5934/4087/4088/4089	12
R-HSA-216083	Integrin cell surface interactions	29/874	65/4579	1.93390202253842e-06	8.58924452978979e-06	4.4371600681597e-06	960/999/1278/2200/2335/3383/3672/8515/3673/3674/3675/3676/3678/3655/3679/8516/3680/3684/3685/3688/3689/3690/3693/3694/3695/3696/3791/6696/3371	29
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	24/874	49/4579	1.94294718378245e-06	8.59584026443831e-06	4.44056739115547e-06	60/1173/1942/1947/2041/1969/2042/2043/2044/285220/2045/2047/2048/2049/2534/4067/4313/4318/5663/5879/6714/7410/10451/7525	24
R-HSA-2559585	Oncogene Induced Senescence	16/874	26/4579	2.11402820720633e-06	9.31647314571161e-06	4.81284267491282e-06	1019/1021/1029/1869/2113/2114/5594/5595/4193/4194/5925/6667/7027/7029/7157/7314	16
R-HSA-422475	Axon guidance	124/874	449/4579	2.20348134042392e-06	9.6731980079614e-06	4.99712492565149e-06	25/27/60/1173/2909/56924/106821730/998/1020/1385/1457/6387/7852/1793/1796/1942/1947/1956/1981/2041/1969/2042/2043/2044/285220/2045/2047/2048/2049/2064/7430/2260/10818/2534/2549/9846/2674/2887/2885/2932/3265/3320/3326/3312/8660/3672/8515/3673/3674/3678/3680/3685/3688/3690/3845/284217/3985/4067/5604/5605/5594/5600/6300/5603/1432/5595/5598/5599/4233/4313/4318/4478/4690/25791/4893/8650/5058/5062/5290/5291/5293/5295/5296/8503/5335/5361/5532/5566/5567/5578/5588/5621/5663/5687/5688/5694/5717/5747/5781/5879/5921/9978/5979/387/388/6091/6195/6196/6197/8986/9252/6237/6383/9037/6464/53358/6477/6654/6714/7314/7408/7410/10451/7525	124
R-HSA-389513	CTLA4 inhibitory signaling	14/874	21/4579	2.35892266821218e-06	1.02762263362347e-05	5.30864629506915e-06	207/208/10000/1493/2534/3932/4067/5515/5518/5519/5528/5781/6714/7525	14
R-HSA-8940973	RUNX2 regulates osteoblast differentiation	14/874	21/4579	2.35892266821218e-06	1.02762263362347e-05	5.30864629506915e-06	25/367/2737/8841/10013/3280/5594/5595/5925/860/6714/25937/10413/7525	14
R-HSA-8983432	Interleukin-15 signaling	11/874	14/4579	2.39670078718169e-06	1.04009495993343e-05	5.37307769886453e-06	9846/2885/3560/3561/3716/3718/6464/6654/6774/6776/6777	11
R-HSA-110056	MAPK3 (ERK1) activation	9/874	10/4579	2.69793608653928e-06	1.16195201908907e-05	6.00258507292231e-06	983/3569/3572/3716/3717/5604/5595/5781/7297	9
R-HSA-442729	CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde	9/874	10/4579	2.69793608653928e-06	1.16195201908907e-05	6.00258507292231e-06	801/805/808/816/818/814/84254/10645/1385	9
R-HSA-442720	CREB1 phosphorylation through the activation of Adenylate Cyclase	10/874	12/4579	2.78659894896907e-06	1.19560868112371e-05	6.17645367835052e-06	107/801/805/808/1385/5566/5567/5573/5577/5613	10
R-HSA-69278	Cell Cycle, Mitotic	105/874	368/4579	2.93488209597361e-06	1.25449659515865e-05	6.48066564920172e-06	25/207/208/10000/64682/10393/51529/29882/29945/51433/6790/9212/8945/8900/890/891/595/894/896/898/9134/902/8881/991/8697/993/246184/996/983/1017/1019/1021/1022/1026/1027/1028/1029/1163/1457/8454/1869/1874/2033/2305/51343/2932/3014/3015/3020/3021/3065/55869/3320/3326/3619/3717/4067/5594/5595/4149/79648/4609/4751/10783/9972/8021/4928/4998/5111/5347/10714/5515/5518/5519/5520/5528/5566/5577/5578/5579/5687/5688/5694/5717/5753/9232/5905/5925/5928/5934/9978/6500/9126/6714/7027/7029/7157/203068/7314/11065/7321/7465/7514/7531/7532	105
R-HSA-525793	Myogenesis	15/874	24/4579	3.37725829572219e-06	1.43818077986372e-05	7.42956881140541e-06	25/998/1000/1495/1499/5608/5600/6300/1432/4205/4208/4209/9043/6929/6925	15
R-HSA-210993	Tie2 Signaling	12/874	17/4579	5.23681651306433e-06	2.22173894602766e-05	1.14773904724662e-05	2885/3265/3845/4893/5290/5291/5295/5296/5781/6464/6654/7010	12
R-HSA-201451	Signaling by BMP	14/874	22/4579	5.35298562621904e-06	2.26258165688143e-05	1.16883818408539e-05	94/650/657/658/659/6497/4086/4089/4090/4091/4092/4093/64750/7321	14
R-HSA-6783783	Interleukin-10 signaling	22/874	45/4579	5.43498377398404e-06	2.28873205593328e-05	1.18234734732284e-05	6347/1230/1234/1437/2919/3383/3586/3592/3593/3606/3553/3554/3557/3569/3716/3976/5724/5743/6774/7124/7132/7297	22
R-HSA-3899300	SUMOylation of transcription cofactors	19/874	36/4579	5.69986061771385e-06	2.39141753591906e-05	1.23539414437146e-05	1387/1487/1616/1655/2033/8648/10499/9612/4869/8204/8554/9063/10401/51588/25942/7341/6613/10155/7329	19
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	40/874	107/4579	5.85930150177881e-06	2.4492741939421e-05	1.26528259984233e-05	640/695/8945/801/805/808/1147/8454/2534/2885/3265/3551/8517/3845/4067/6885/4690/4772/4773/4775/4790/4792/4893/5293/5295/5530/5532/5534/5579/5687/5688/5694/5717/5777/5970/6500/6654/6850/7314/7409	40
R-HSA-418594	G alpha (i) signalling events	73/874	237/4579	5.96048955850249e-06	2.4824456512884e-05	1.28241880610927e-05	107/108/113/301/351/801/805/808/815/816/817/818/814/84254/10645/1230/2826/1232/1233/1234/1235/1236/10803/1020/1385/1524/2919/6387/2921/6374/3577/3579/2833/7852/643/10663/2770/2773/2775/2781/2782/2783/10681/54331/2719/23566/4023/5594/5330/5331/5443/5515/5518/5519/5528/5530/5532/5533/5534/5566/5567/5573/5577/5578/5580/5582/5588/5613/6288/6382/6383/6385/6714	73
R-HSA-195258	RHO GTPase Effectors	69/874	221/4579	6.4564449884622e-06	2.6791890335334e-05	1.38405543740373e-05	25/60/367/9212/695/801/805/808/991/998/999/1027/1495/1499/2017/23002/1729/1855/1856/1857/2885/3014/3015/3020/3021/3619/3688/3985/5594/5600/1432/5595/4638/653361/4690/10499/4771/4928/5058/5062/5289/5300/5585/5347/5515/5518/5519/5528/5578/5579/5580/5590/5747/5879/5880/5905/387/388/23433/2810/6714/6722/7514/7529/7531/7532/7533/10971/7534	69
R-HSA-1839126	FGFR2 mutant receptor activation	16/874	28/4579	8.22463193470815e-06	3.38819076440694e-05	1.75032212798137e-05	2246/8822/8817/2247/26281/27006/8074/2250/2252/2253/2254/2263/2962/5431/5432/5439	16
R-HSA-8864260	Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	16/874	28/4579	8.22463193470815e-06	3.38819076440694e-05	1.75032212798137e-05	1026/4435/1387/1956/2033/2064/2099/3815/4609/4869/7341/7020/7039/7329/7422/7528	16
R-HSA-69620	Cell Cycle Checkpoints	64/874	202/4579	8.29592124728637e-06	3.40522110403054e-05	1.75911991487205e-05	64682/10393/51529/29882/29945/51433/472/545/9212/580/641/672/8900/890/891/898/9134/8881/991/8697/993/246184/996/983/1017/1026/1027/1029/1111/11200/3014/3619/10524/9656/4193/4194/4928/4998/51588/5347/5515/5518/5519/5528/5687/5688/5694/5717/5905/2810/7341/11073/7157/7314/11065/7321/7465/7514/7529/7531/7532/7533/10971/7534	64
R-HSA-2682334	EPH-Ephrin signaling	34/874	87/4579	9.67803981285233e-06	3.9582486572709e-05	2.04481113804301e-05	60/1173/998/1942/1947/2041/1969/2042/2043/2044/285220/2045/2047/2048/2049/2534/3265/3985/4067/4313/4318/25791/5058/5062/5663/5747/5879/5921/387/6383/6714/7410/10451/7525	34
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	24/874	53/4579	1.09335887321623e-05	4.45573132203174e-05	2.30180815413944e-05	351/596/598/835/841/842/1147/3326/3551/8517/83737/5608/6885/5600/6300/5603/1432/4790/5970/10454/23118/7189/7295/7314	24
R-HSA-1592230	Mitochondrial biogenesis	23/874	50/4579	1.21003231121912e-05	4.8961093873884e-05	2.52930522442506e-05	1386/801/805/808/814/1385/1387/54205/8841/5600/6300/1432/4208/4209/8648/10499/9611/5465/5563/5564/6256/6648/79718	23
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	23/874	50/4579	1.21003231121912e-05	4.8961093873884e-05	2.52930522442506e-05	896/1019/1024/1051/1387/2033/8841/9314/4023/8648/10499/8202/9611/9612/4790/5465/5468/5970/6256/6720/79718/7040/7124	23
R-HSA-2025928	Calcineurin activates NFAT	9/874	11/4579	1.23156342401379e-05	4.94801276715081e-05	2.55611824660478e-05	801/805/808/4772/4773/4775/5530/5532/5534	9
R-HSA-9028731	Activated NTRK2 signals through FRS2 and FRS3	9/874	11/4579	1.23156342401379e-05	4.94801276715081e-05	2.55611824660478e-05	627/10818/2885/3265/3845/4893/4915/5781/6654	9
R-HSA-6804114	TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest	12/874	18/4579	1.29886659649436e-05	5.20003985990878e-05	2.68631416176373e-05	6790/891/983/1874/2033/1647/5111/5934/2810/7027/7029/7157	12
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	32/874	81/4579	1.35836405937593e-05	5.40020956472178e-05	2.7897208138821e-05	64682/10393/51529/29882/29945/51433/6790/9212/8945/8900/890/891/8881/991/8697/246184/996/983/1017/8454/51343/4751/5347/5687/5688/5694/5717/9232/6500/7314/11065/7321	32
R-HSA-453276	Regulation of mitotic cell cycle	32/874	81/4579	1.35836405937593e-05	5.40020956472178e-05	2.7897208138821e-05	64682/10393/51529/29882/29945/51433/6790/9212/8945/8900/890/891/8881/991/8697/246184/996/983/1017/8454/51343/4751/5347/5687/5688/5694/5717/9232/6500/7314/11065/7321	32
R-HSA-76009	Platelet Aggregation (Plug Formation)	17/874	32/4579	1.59581212853917e-05	6.3220849830977e-05	3.26595696946583e-05	207/9564/1278/1398/1445/2335/2885/3674/3690/5747/5906/5908/10235/6464/6654/6714/6850	17
R-HSA-8875878	MET promotes cell motility	18/874	35/4579	1.61682325429845e-05	6.38308347269909e-05	3.29746847916132e-05	1278/1398/1399/2335/2549/2885/3082/3673/3675/3688/284217/4233/5747/5879/5906/5908/2889/6714	18
R-HSA-112315	Transmission across Chemical Synapses	52/874	158/4579	1.84740367352273e-05	7.26815908925724e-05	3.75469404416566e-05	107/108/113/1173/773/801/805/808/8536/815/816/817/818/814/84254/10645/1385/2066/2770/2773/2782/2783/10681/54331/2903/3265/3312/3845/5594/5595/4193/4893/3084/5330/5331/5562/5563/5564/5566/5567/5573/5577/5578/5579/5582/5613/5879/5923/6195/6196/6197/6714	52
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	11/874	16/4579	1.96996086333588e-05	7.72360517797549e-05	3.98997517873473e-05	993/1869/1874/3065/4149/4609/5111/5928/5934/7027/7029	11
R-HSA-69206	G1/S Transition	42/874	120/4579	2.29323257504365e-05	8.96015614372725e-05	4.62877112271426e-05	207/208/10000/8900/890/891/595/898/9134/902/993/983/1017/1019/1022/1026/1027/1163/8454/1869/1874/3065/4149/4609/4998/5111/5515/5518/5519/5687/5688/5694/5717/5753/5925/5928/5934/6500/7027/7029/7314/7465	42
R-HSA-202433	Generation of second messenger molecules	15/874	27/4579	2.51988791430055e-05	9.81202931013605e-05	5.06884447072714e-05	919/915/916/917/920/3122/3123/27040/3932/3937/4690/5058/5062/5335/7408	15
R-HSA-373752	Netrin-1 signaling	19/874	39/4579	2.54986272342702e-05	9.89485978340111e-05	5.11163427221943e-05	998/1793/7430/2534/5600/6300/5603/1432/5599/4690/5058/5335/5588/5747/5781/5879/6091/6477/6714	19
R-HSA-180336	SHC1 events in EGFR signaling	10/874	14/4579	2.90288322833816e-05	0.000111130580155572	5.74094928730353e-05	374/1950/1956/2885/3265/3845/4893/6464/6654/7039	10
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	10/874	14/4579	2.90288322833816e-05	0.000111130580155572	5.74094928730353e-05	9846/2885/9208/5290/5295/6772/6774/6776/6777/8805	10
R-HSA-3371568	Attenuation phase	10/874	14/4579	2.90288322833816e-05	0.000111130580155572	5.74094928730353e-05	1387/2033/2288/3281/3297/3320/3326/3303/3304/3312	10
R-HSA-6804116	TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest	10/874	14/4579	2.90288322833816e-05	0.000111130580155572	5.74094928730353e-05	1820/8900/890/898/9134/1017/1026/1027/1869/7157	10
R-HSA-111931	PKA-mediated phosphorylation of CREB	12/874	19/4579	2.91547210344781e-05	0.000111237979248999	5.746497469883e-05	107/108/113/801/805/808/1385/5566/5567/5573/5577/5613	12
R-HSA-168928	DDX58/IFIH1-mediated induction of interferon-alpha/beta	25/874	59/4579	2.95339276245952e-05	0.000112307945515601	5.8017713833917e-05	351/843/841/1147/1387/2033/8772/3551/9641/8517/3661/83737/4214/57506/4790/4792/5094/5300/5970/8737/6288/7186/7189/7314/7321	25
R-HSA-373760	L1CAM interactions	33/874	88/4579	3.56530124983957e-05	0.00013512491736892	6.98048455231748e-05	60/1173/1457/1956/2048/7430/2260/3312/3672/8515/3673/3674/3678/3680/3685/3688/3690/284217/5604/5605/5594/5595/4478/8650/5058/5879/6195/6196/6197/8986/9252/6714/7410	33
R-HSA-913531	Interferon Signaling	44/874	130/4579	3.79530176575768e-05	0.000143364056733106	7.40611430422377e-05	567/815/816/817/818/960/4261/1958/5610/1977/1981/3105/3122/3123/3133/3383/3458/3459/3661/10379/3716/3717/3837/5595/9972/8021/4928/8554/5300/5335/5371/5580/5724/5781/5771/5777/8651/9021/6672/6772/6773/7341/7297/7314	44
R-HSA-2029481	FCGR activation	9/874	12/4579	4.09027401136443e-05	0.00015248005084988	7.87704192697619e-05	919/917/2214/2268/2534/4067/6714/6850/7525	9
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins 	9/874	12/4579	4.09027401136443e-05	0.00015248005084988	7.87704192697619e-05	2335/2885/3674/3690/5747/5906/5908/6654/6714	9
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	9/874	12/4579	4.09027401136443e-05	0.00015248005084988	7.87704192697619e-05	9564/1398/2335/3674/3690/5747/5906/5908/6714	9
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	9/874	12/4579	4.09027401136443e-05	0.00015248005084988	7.87704192697619e-05	801/805/808/4772/4773/4775/5530/5532/5534	9
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	14/874	25/4579	4.1977214516883e-05	0.000155974159822536	8.05754582057815e-05	23327/4087/4088/4092/64750/11171/10273/7040/7046/7048/7314/51377/7514/9372	14
R-HSA-4791275	Signaling by WNT in cancer	17/874	34/4579	4.4713959381182e-05	0.00016560186259415	8.55490805235713e-05	324/8312/1452/1487/1499/8322/7855/8323/8325/2932/4040/5515/5518/5519/5528/6934/89780	17
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	16/874	31/4579	4.55462509643857e-05	0.000168136647228917	8.68585373825263e-05	867/23327/4087/4088/4089/4092/64750/11171/10273/7040/7046/7048/7314/51377/7514/9372	16
R-HSA-442982	Ras activation upon Ca2+ influx through NMDA receptor	11/874	17/4579	4.62147275205654e-05	0.000170052249808683	8.78481279389389e-05	801/805/808/815/816/817/818/3265/3845/4893/5923	11
R-HSA-69473	G2/M DNA damage checkpoint	24/874	57/4579	4.82348253554638e-05	0.000176912891706975	9.13923006735104e-05	472/545/580/641/672/891/983/1111/11200/3014/10524/9656/51588/2810/7341/11073/7157/7465/7529/7531/7532/7533/10971/7534	24
R-HSA-8866910	TFAP2 (AP-2) family regulates transcription of growth factors and their receptors	8/874	10/4579	5.34407338507333e-05	0.000194750366629115	0.000100607049557049	1956/2064/2099/3815/7020/7039/7422/7528	8
R-HSA-9617629	Regulation of FOXO transcriptional activity by acetylation	8/874	10/4579	5.34407338507333e-05	0.000194750366629115	0.000100607049557049	1387/2033/2308/2309/4303/8850/23411/7295	8
R-HSA-400253	Circadian Clock	25/874	61/4579	5.79852812950706e-05	0.000210636628857812	0.000108813811880442	1386/8945/1385/1387/1390/8454/2033/8841/3091/4208/4209/8648/10499/9611/2908/8204/5187/5465/6256/5054/23411/6500/6720/79718/7314	25
R-HSA-2029485	Role of phospholipids in phagocytosis	12/874	20/4579	6.02912166840296e-05	0.000218315647674336	0.000112780753971467	919/917/2214/5290/5291/5295/5296/5335/5337/5580/5581/6850	12
R-HSA-9020591	Interleukin-12 signaling	18/874	38/4579	6.69019747548222e-05	0.000241484270781692	0.000124749546911247	302/375/998/3458/3586/3592/3593/3594/3595/3716/3717/4282/4478/5062/27250/5908/6648/7297	18
R-HSA-73887	Death Receptor Signalling	41/874	121/4579	6.75915193952619e-05	0.000243201131494977	0.000125636468429567	6868/396/572/10018/843/835/836/841/1147/8772/355/356/10672/3065/3066/8841/3551/8517/6885/5599/4790/4792/25791/5584/5663/5879/5970/387/8737/6654/10454/23118/7124/7132/7186/7189/7314/7409/7410/10451/7531	41
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	13/874	23/4579	6.99136110746091e-05	0.000250762699658771	0.00012954273611035	5594/5600/1432/5595/653361/5289/5300/5578/5579/5580/5590/5879/5880	13
R-HSA-1963640	GRB2 events in ERBB2 signaling	10/874	15/4579	7.22119729920064e-05	0.000257382486808499	0.000132962484505988	1950/1956/2064/2066/2885/3265/3845/4893/3084/6654	10
R-HSA-1963642	PI3K events in ERBB2 signaling	10/874	15/4579	7.22119729920064e-05	0.000257382486808499	0.000132962484505988	1950/1956/2064/2065/2066/2549/2885/3084/5290/5295	10
R-HSA-447115	Interleukin-12 family signaling	21/874	48/4579	7.27842184822357e-05	0.000258611426294694	0.000133597348398314	302/375/998/3458/3586/3592/3593/3594/3595/3572/3716/3717/4282/4478/5062/27250/5908/6648/6772/6774/7297	21
R-HSA-3928663	EPHA-mediated growth cone collapse	14/874	26/4579	7.51128153782572e-05	0.00026605380400336	0.000137442042895778	1942/2041/1969/2042/2043/2044/285220/2045/2534/4067/25791/387/6714/7525	14
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	15/874	29/4579	7.65623090986439e-05	0.000270345793307944	0.000139659262755944	408/2149/2767/2768/10672/9630/2769/2776/2782/2783/10681/54331/5594/5595/6714	15
R-HSA-202424	Downstream TCR signaling	33/874	91/4579	7.77283136952958e-05	0.000273613290004803	0.000141347234942073	8945/919/915/916/917/920/1147/8454/3122/3123/3551/8517/3635/3932/6885/4790/4792/5290/5291/5295/5296/5588/5687/5688/5694/5717/5728/5970/6500/23118/7189/7314/7321	33
R-HSA-201681	TCF dependent signaling in response to WNT	53/874	170/4579	8.16854333898535e-05	0.000286655363469949	0.000148084703806167	207/208/324/8312/8945/857/1387/1452/1455/1457/1487/1499/1855/1856/1857/2033/10023/8321/2535/8322/7855/8323/8325/2932/3014/3015/3020/3021/3065/10524/51176/4040/4609/5515/5518/5519/5528/5687/5688/5694/5717/9978/6259/6422/64750/6662/6932/83439/6934/7314/89780/7514/7534	53
R-HSA-9620244	Long-term potentiation	11/874	18/4579	9.84271099651143e-05	0.000344343458554877	0.000177886080519948	801/805/808/815/816/817/818/2066/2903/3084/6714	11
R-HSA-380108	Chemokine receptors bind chemokines	21/874	49/4579	0.000104849211797759	0.000365685747895866	0.000188911398718597	6347/1230/2826/1232/1233/1234/1235/1236/10803/1524/2919/6387/2921/6374/3577/3579/2833/7852/643/10663/2829	21
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	23/874	56/4579	0.000109831111775813	0.000380449408447036	0.000196538230721146	25/60/695/919/917/998/1398/1793/2214/2885/3320/3326/5594/5595/4690/4771/5058/5747/5879/6850/7409/7410/10451	23
R-HSA-1362300	Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1	9/874	13/4579	0.000110420672636343	0.000380449408447036	0.000196538230721146	890/983/1869/1874/3065/5928/5934/7027/7029	9
R-HSA-171007	p38MAPK events	9/874	13/4579	0.000110420672636343	0.000380449408447036	0.000196538230721146	3265/3845/5600/6300/5603/1432/9261/4893/6714	9
R-HSA-179812	GRB2 events in EGFR signaling	9/874	13/4579	0.000110420672636343	0.000380449408447036	0.000196538230721146	374/1950/1956/2885/3265/3845/4893/6654/7039	9
R-HSA-168638	NOD1/2 Signaling Pathway	17/874	36/4579	0.000111970261803207	0.000384622923475063	0.000198694247372203	835/841/842/1147/3551/8517/83737/5608/6885/5600/6300/5603/1432/10454/23118/7189/7314	17
R-HSA-3371556	Cellular response to heat stress	28/874	74/4579	0.000115211985360305	0.000394566347453816	0.000203830969660908	472/545/815/816/817/818/1387/2033/2288/2932/10013/3281/3297/3320/3326/3303/3304/3312/5594/5595/9261/2475/9972/8021/4928/57521/23411/7531	28
R-HSA-8862803	Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models	12/874	21/4579	0.000116400804272142	0.000396250642088099	0.000204701067708336	351/10018/823/824/993/1020/356/2309/3725/5052/6648/7531	12
R-HSA-8863678	Neurodegenerative Diseases	12/874	21/4579	0.000116400804272142	0.000396250642088099	0.000204701067708336	351/10018/823/824/993/1020/356/2309/3725/5052/6648/7531	12
R-HSA-397795	G-protein beta:gamma signalling	15/874	30/4579	0.000126400545924055	0.00042773041879658	0.000220963360355961	207/208/10000/695/998/2782/2783/10681/54331/5058/5294/23533/5330/5331/387	15
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	15/874	30/4579	0.000126400545924055	0.00042773041879658	0.000220963360355961	640/695/801/805/808/2534/2885/4067/4690/5293/5295/5777/6654/6850/7409	15
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	28/874	75/4579	0.000151106110387424	0.000509814977775969	0.000263367826319484	64682/10393/51529/29882/29945/51433/8945/8900/890/891/8881/991/8697/246184/996/983/1017/8454/51343/5347/5687/5688/5694/5717/6500/7314/11065/7321	28
R-HSA-1295596	Spry regulation of FGF signaling	10/874	16/4579	0.000159732580256419	0.00053416454044573	0.000275946686634928	673/867/2885/5594/5595/5515/5518/5781/6714/7314	10
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	10/874	16/4579	0.000159732580256419	0.00053416454044573	0.000275946686634928	8945/1147/8454/3551/8517/5604/6416/4790/6500/7314	10
R-HSA-9617324	Negative regulation of NMDA receptor-mediated neuronal transmission	10/874	16/4579	0.000159732580256419	0.00053416454044573	0.000275946686634928	801/805/808/8536/815/816/817/818/814/2903	10
R-HSA-1170546	Prolactin receptor signaling	8/874	11/4579	0.000163107666145655	0.000537546134514811	0.000277693600943632	8945/8454/3717/5781/9978/6500/6776/6777	8
R-HSA-2586552	Signaling by Leptin	8/874	11/4579	0.000163107666145655	0.000537546134514811	0.000277693600943632	3667/8660/3717/5781/9021/6774/6776/6777	8
R-HSA-4755510	SUMOylation of immune response proteins	8/874	11/4579	0.000163107666145655	0.000537546134514811	0.000277693600943632	9641/8517/4792/10401/51588/5970/7341/7329	8
R-HSA-6803207	TP53 Regulates Transcription of Caspase Activators and Caspases	8/874	11/4579	0.000163107666145655	0.000537546134514811	0.000277693600943632	317/472/843/835/839/7157/8626/7161	8
R-HSA-8851805	MET activates RAS signaling	8/874	11/4579	0.000163107666145655	0.000537546134514811	0.000277693600943632	2885/3082/3265/3845/4233/4893/6464/6654	8
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	11/874	19/4579	0.000193676644744738	0.000636446084031119	0.000328784812192163	919/915/916/917/920/1445/3122/3123/3932/55824/5795	11
R-HSA-383280	Nuclear Receptor transcription pathway	19/874	44/4579	0.000197657699755	0.000647656497468113	0.000334576054795359	367/2099/2100/3172/9611/9612/8431/7182/2908/3164/2516/5465/5468/5914/5916/6256/6257/7067/7421	19
R-HSA-392518	Signal amplification	14/874	28/4579	0.0002129480213414	0.000695752586968883	0.000359422250176954	2767/10672/9630/2769/2770/2773/2776/2782/2783/10681/54331/1432/6714/6915	14
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	18/874	41/4579	0.000225479458033558	0.000732486125097589	0.000378398609271355	1386/801/805/808/814/1385/1387/54205/8841/4208/4209/8648/10499/9611/5465/6256/6648/79718	18
R-HSA-3928662	EPHB-mediated forward signaling	18/874	41/4579	0.000225479458033558	0.000732486125097589	0.000378398609271355	60/998/1947/2047/2048/2049/2534/3265/3985/4067/5058/5747/5879/5921/387/6383/6714/7525	18
R-HSA-5607764	CLEC7A (Dectin-1) signaling	33/874	96/4579	0.000252640550569774	0.000818382638170464	0.000422772311344831	8945/801/805/808/841/1147/8454/3551/8517/3553/6885/4772/4773/4775/4790/4792/5530/5532/5534/5580/5687/5688/5694/5717/5970/6500/6714/6850/10454/23118/7189/7314/7321	33
R-HSA-5628897	TP53 Regulates Metabolic Genes	21/874	52/4579	0.000287750398210095	0.000929466485127493	0.000480157662085026	207/208/10000/54205/2475/5052/5562/5563/5564/5728/57521/2810/7157/8626/7295/7529/7531/7532/7533/10971/7534	21
R-HSA-163615	PKA activation	10/874	17/4579	0.000321900941307637	0.00103390217589487	0.000534108609127748	107/108/113/801/805/808/5566/5567/5573/5577	10
R-HSA-196299	Beta-catenin phosphorylation cascade	10/874	17/4579	0.000321900941307637	0.00103390217589487	0.000534108609127748	324/8312/1452/1499/10023/2932/5515/5518/5519/5528	10
R-HSA-9616222	Transcriptional regulation of granulopoiesis	20/874	49/4579	0.000338122491319597	0.00108294442994474	0.000559443588306405	1017/1019/1026/1051/1385/1869/2033/2672/3014/3015/3020/3021/51176/4609/5371/5914/6256/6774/7027/7029	20
R-HSA-389948	PD-1 signaling	11/874	20/4579	0.00035670327904116	0.00113924614682528	0.000588528769086243	919/915/916/917/920/1445/3122/3123/3932/5781/5777	11
R-HSA-186712	Regulation of beta-cell development	13/874	26/4579	0.000359363161443425	0.00114132937028261	0.000589604951736051	207/208/10000/1387/2033/2308/2645/3280/3172/2648/8850/4851/3516	13
R-HSA-8863795	Downregulation of ERBB2 signaling	13/874	26/4579	0.000359363161443425	0.00114132937028261	0.000589604951736051	207/208/10000/1950/1956/2064/2065/2066/3320/3084/5782/10273/7314	13
R-HSA-389359	CD28 dependent Vav1 pathway	8/874	12/4579	0.000407517518209675	0.00127996524365856	0.000661223539287579	998/2534/2885/3932/5058/5062/5879/7409	8
R-HSA-8984722	Interleukin-35 Signalling	8/874	12/4579	0.000407517518209675	0.00127996524365856	0.000661223539287579	3592/3595/3572/3716/3717/6772/6774/7297	8
R-HSA-912694	Regulation of IFNA signaling	8/874	12/4579	0.000407517518209675	0.00127996524365856	0.000661223539287579	3716/5781/5777/8651/9021/6772/6773/7297	8
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	8/874	12/4579	0.000407517518209675	0.00127996524365856	0.000661223539287579	843/841/1147/8772/3551/8517/57506/8737	8
R-HSA-3000171	Non-integrin membrane-ECM interactions	20/874	50/4579	0.000464320074177914	0.00145435791829281	0.00075131390863064	1278/780/4921/2247/2335/3673/3655/3685/3688/3690/3691/3693/284217/5155/5578/6382/6383/6385/7040/3371	20
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	28/874	80/4579	0.000524836606973788	0.00163939346738791	0.000846902332826414	8945/801/805/808/1147/8454/3265/3551/8517/3845/6885/4772/4773/4775/4790/4792/4893/5530/5532/5534/5579/5687/5688/5694/5717/5970/6500/7314	28
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	9/874	15/4579	0.000533997003691172	0.00163956883982901	0.000846992929338138	324/8312/1452/1499/2932/5515/5518/5519/5528	9
R-HSA-5675221	Negative regulation of MAPK pathway	17/874	40/4579	0.000534986842195747	0.00163956883982901	0.000846992929338138	369/673/3265/3845/8844/5604/5605/5594/5595/4893/5515/5518/5519/5528/5894/7314/7529	17
R-HSA-5688426	Deubiquitination	55/874	191/4579	0.000591184659774832	0.00180692730689243	0.000933449462802366	60/154/324/367/408/8312/580/672/8900/890/991/993/983/2033/2099/4303/2625/9146/3091/3416/8517/2648/8850/6885/57506/4193/4194/4609/4792/5687/5688/5694/5717/5728/387/8737/79589/4086/4087/4088/4089/4092/64750/10454/6881/7040/7046/7048/7157/7186/7189/7314/7321/51377/7528	55
R-HSA-113510	E2F mediated regulation of DNA replication	10/874	18/4579	0.000601243230485793	0.00183274411008672	0.000946786292115345	891/983/1869/4998/5515/5518/5519/5925/7027/7029	10
R-HSA-933542	TRAF6 mediated NF-kB activation	12/874	24/4579	0.000607683208544251	0.00184742194683105	0.000954368787975491	351/1147/3551/8517/4214/57506/4790/4792/5970/6288/7186/7189	12
R-HSA-376172	DSCAM interactions	7/874	10/4579	0.00063137408293435	0.0019041706426959	0.000983684875826797	5600/6300/5603/1432/5599/5058/5879	7
R-HSA-399997	Acetylcholine regulates insulin secretion	7/874	10/4579	0.00063137408293435	0.0019041706426959	0.000983684875826797	2767/9630/2769/2776/5330/5331/5578	7
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	7/874	10/4579	0.00063137408293435	0.0019041706426959	0.000983684875826797	595/894/896/1021/5371/5781/6714	7
R-HSA-446652	Interleukin-1 family signaling	39/874	125/4579	0.000691679522398607	0.00208052808721486	0.00107479023530611	351/8945/1147/8454/3551/8517/3596/3606/3553/3554/3557/3565/5604/6416/5608/4215/6885/5599/4790/4792/5687/5688/5694/5717/5781/5782/5771/5777/5778/9978/5970/6288/6500/4088/6774/10454/23118/7189/7314	39
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	15/874	34/4579	0.000703716826868958	0.00211115048060687	0.00109060960809021	207/208/324/8945/1487/1499/3065/51176/6662/6932/83439/6934/7314/7514/7534	15
R-HSA-1266695	Interleukin-7 signaling	14/874	31/4579	0.000795123150421526	0.00237909216323493	0.00122902691948812	3082/3561/3667/8660/3716/3718/5295/5296/8503/8651/8835/6774/6776/6777	14
R-HSA-1250347	SHC1 events in ERBB4 signaling	8/874	13/4579	0.000882872471127009	0.00262095561271909	0.00135397234818983	2066/2885/3265/3845/4893/3084/6464/6654	8
R-HSA-428540	Activation of RAC1	8/874	13/4579	0.000882872471127009	0.00262095561271909	0.00135397234818983	56924/106821730/4690/5058/5062/5879/6091/6654	8
R-HSA-8941856	RUNX3 regulates NOTCH signaling	8/874	13/4579	0.000882872471127009	0.00262095561271909	0.00135397234818983	1387/2033/3280/182/2648/8850/4851/3516	8
R-HSA-416476	G alpha (q) signalling events	43/874	143/4579	0.000885774163016863	0.00262272193580774	0.00135488482171987	301/351/695/1385/1906/1956/2149/2150/2767/9630/2769/2776/2782/2783/10681/54331/2885/3265/3845/23566/5594/5595/5598/4893/5290/5295/5296/8503/5330/5331/5578/5580/5581/5588/5724/10235/6195/6196/6197/6288/6654/6915/2829	43
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	25/874	71/4579	0.000931607919127627	0.00275126806246263	0.00142129109739772	64682/10393/51529/29882/29945/51433/8900/890/891/8881/991/8697/246184/996/983/4751/5347/5687/5688/5694/5717/9232/7314/11065/7321	25
R-HSA-69205	G1/S-Specific Transcription	12/874	25/4579	0.00096809418097509	0.00285161420665461	0.00147312940546523	8900/898/983/1869/1874/3065/4998/5111/5928/5934/7027/7029	12
R-HSA-6783589	Interleukin-6 family signaling	11/874	22/4579	0.00103012486766931	0.00301869065603093	0.0015594402500257	867/3569/3572/3716/3717/3976/5781/9021/6772/6774/7297	11
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	11/874	22/4579	0.00103012486766931	0.00301869065603093	0.0015594402500257	207/208/10000/2033/3065/3066/5608/5300/5371/5928/7157	11
R-HSA-8943724	Regulation of PTEN gene transcription	18/874	46/4579	0.00120021950968362	0.00350809661313695	0.00181226487999854	1386/1958/2146/3065/3066/8841/10014/51564/3725/5594/5595/9112/2475/5468/5928/57521/6615/7157	18
R-HSA-8878171	Transcriptional regulation by RUNX1	47/874	163/4579	0.00141267955904553	0.00411850425290966	0.00212759836423051	25/8312/640/595/894/896/902/1021/1022/1387/1437/1457/1493/2033/2099/50943/2625/3014/3015/3020/3021/3065/3458/3559/83737/3674/8850/3958/4773/5371/5579/5588/5687/5688/5694/5717/5781/860/25942/6601/9021/122809/6714/6929/7161/7314/10413	47
R-HSA-418885	DCC mediated attractive signaling	7/874	11/4579	0.00145084031231457	0.0042189397317178	0.00217948282210668	998/1793/2534/4690/5747/5879/6714	7
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalling pathway	12/874	26/4579	0.00148986362628795	0.00432136465073826	0.00223239501468495	836/841/842/1612/1613/8772/355/356/8737/148022/7099/7186	12
R-HSA-69052	Switching of origins to a post-replicative state	27/874	81/4579	0.00153097598628894	0.00442931220460694	0.00228816017235631	64682/10393/51529/29882/29945/51433/8900/890/898/9134/8881/8697/246184/996/1017/8454/51343/4998/5687/5688/5694/5717/9978/6500/7314/11065/7321	27
R-HSA-112409	RAF-independent MAPK1/3 activation	11/874	23/4579	0.00163808759887315	0.0047271715733979	0.00244203280836553	983/3569/3572/3716/3717/5604/5605/5594/5595/5781/7297	11
R-HSA-165159	mTOR signalling	14/874	33/4579	0.00167978398153593	0.00482163178327925	0.00249083047268419	207/208/1977/1978/1981/2475/5494/5562/5563/5564/6198/57521/6794/7529	14
R-HSA-418597	G alpha (z) signalling events	16/874	40/4579	0.00169478279616364	0.00482163178327925	0.00249083047268419	107/108/113/2770/2773/2781/2782/2783/10681/54331/5578/5579/5580/5581/5582/5588	16
R-HSA-392517	Rap1 signalling	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	5566/5567/5894/5906/5908/10235/7529/7534	8
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	324/8312/1452/2932/5515/5518/5519/5528	8
R-HSA-6785631	ERBB2 Regulates Cell Motility	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	1729/1950/1956/2064/2065/2066/3084/387	8
R-HSA-75892	Platelet Adhesion to exposed collagen	8/874	14/4579	0.00171746778560079	0.00482163178327925	0.00249083047268419	1278/2207/2534/3672/8515/3673/3688/4067	8
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	10/874	20/4579	0.00175148670579943	0.00490502557757132	0.00253391128295588	1147/3551/8517/3661/4790/4792/5970/8737/11035/148022	10
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	24/874	70/4579	0.00178471686201496	0.00498580607398282	0.0025756420768249	64682/10393/51529/29882/29945/51433/8900/890/891/8881/991/8697/246184/996/983/4751/5687/5688/5694/5717/9232/7314/11065/7321	24
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	9/874	17/4579	0.0017951489450426	0.00500265772184666	0.00258434755246071	1147/3551/8517/4790/4792/5970/8737/11035/148022	9
R-HSA-1912422	Pre-NOTCH Expression and Processing	20/874	55/4579	0.00189373560832762	0.00526449238794255	0.0027196100101578	595/1387/1869/2033/3014/3015/3020/3021/3725/2648/8850/3955/4242/4851/23509/5584/3516/7027/7029/7157	20
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	23/874	67/4579	0.00216686538226322	0.005979917329207	0.00308919489857659	64682/10393/51529/29882/29945/51433/6790/9212/8881/991/8697/246184/996/51343/5347/5687/5688/5694/5717/9232/7314/11065/7321	23
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	23/874	67/4579	0.00216686538226322	0.005979917329207	0.00308919489857659	64682/10393/51529/29882/29945/51433/8900/890/898/9134/8881/8697/246184/996/1017/51343/5687/5688/5694/5717/7314/11065/7321	23
R-HSA-69618	Mitotic Spindle Checkpoint	23/874	67/4579	0.00216686538226322	0.005979917329207	0.00308919489857659	64682/10393/51529/29882/29945/51433/9212/8881/991/8697/246184/996/3619/4928/5347/5515/5518/5519/5528/5905/11065/7321/7514	23
R-HSA-3000178	ECM proteoglycans	20/874	56/4579	0.0024294673610825	0.00668838835242326	0.00345518742827587	351/54829/1278/2335/3673/3674/3679/8516/3680/3685/3688/3690/3693/3694/284217/5054/7040/7042/7043/3371	20
R-HSA-389357	CD28 dependent PI3K/Akt signaling	10/874	21/4579	0.00277916916444702	0.00761425383126811	0.00393348482881785	207/208/10000/2534/3932/2475/5290/5295/5296/8503	10
R-HSA-428930	Thromboxane signalling through TP receptor	10/874	21/4579	0.00277916916444702	0.00761425383126811	0.00393348482881785	2767/10672/9630/2769/2776/2782/2783/10681/54331/6915	10
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	7/874	12/4579	0.00291149222406142	0.00791953746114314	0.00409119280036835	1490/8850/4878/860/7003/25937/10413	7
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	7/874	12/4579	0.00291149222406142	0.00791953746114314	0.00409119280036835	1387/2033/3280/2648/8850/4851/3516	7
R-HSA-8847993	ERBB2 Activates PTK6 Signaling	7/874	12/4579	0.00291149222406142	0.00791953746114314	0.00409119280036835	1950/1956/2064/2065/2066/3084/5753	7
R-HSA-8876384	Listeria monocytogenes entry into host cells	9/874	18/4579	0.00298905465959941	0.00811111013834017	0.00419015827171579	867/999/1499/1500/2885/9146/4233/6714/7314	9
R-HSA-1368082	RORA activates gene expression	8/874	15/4579	0.00307000582206893	0.00831094433260088	0.00429339160078812	1387/2033/8648/10499/5465/6256/6720/79718	8
R-HSA-1251985	Nuclear signaling by ERBB4	12/874	28/4579	0.00322597790632662	0.00871243914368972	0.00450080177954808	6868/6387/2066/2099/9611/3084/5663/6714/6776/3925/23118/10413	12
R-HSA-75893	TNF signaling	14/874	35/4579	0.00325992467376481	0.00878325676320045	0.00453738580184775	6868/841/1147/8772/3551/8517/6885/8737/10454/23118/7124/7132/7186/7314	14
R-HSA-1912408	Pre-NOTCH Transcription and Translation	17/874	46/4579	0.00334229564356672	0.00896711960502021	0.00463236841142552	595/1387/1869/2033/3014/3015/3020/3021/3725/2648/8850/4851/5584/3516/7027/7029/7157	17
R-HSA-163685	Integration of energy metabolism	27/874	85/4579	0.00335182570988003	0.00896711960502021	0.00463236841142552	107/108/113/773/2767/9630/2769/2770/2776/2782/2783/10681/54331/5330/5331/5515/5518/5519/5528/5563/5566/5567/5573/5577/5578/5906/6794	27
R-HSA-193704	p75 NTR receptor-mediated signalling	27/874	85/4579	0.00335182570988003	0.00896711960502021	0.00463236841142552	6868/396/572/10018/835/836/10672/3065/3066/8841/3551/5599/4790/4792/25791/5584/5663/5879/5970/387/6654/7189/7314/7409/7410/10451/7531	27
R-HSA-5689896	Ovarian tumor domain proteases	13/874	32/4579	0.00386613593281258	0.0103187712572955	0.00533062478504922	324/983/2099/8517/57506/5728/387/8737/79589/7157/7189/7314/7321	13
R-HSA-1500931	Cell-Cell communication	25/874	78/4579	0.00409528955838984	0.0108793089436665	0.00562019570482422	60/999/1000/1495/1499/1500/2534/2885/3611/3655/3688/3691/4690/5290/5291/5295/5296/5584/5747/2185/5781/5777/5829/6714/7408	25
R-HSA-195253	Degradation of beta-catenin by the destruction complex	25/874	78/4579	0.00409528955838984	0.0108793089436665	0.00562019570482422	324/8312/8945/1452/1487/1499/8454/10023/2932/3065/51176/5515/5518/5519/5528/5687/5688/5694/5717/9978/6500/6932/83439/6934/7314	25
R-HSA-1852241	Organelle biogenesis and maintenance	37/874	128/4579	0.00419638784514386	0.0111218950581085	0.00574551445857017	50807/1386/801/805/808/814/983/1385/1387/54205/8729/8841/10013/3320/5600/6300/1432/4208/4209/8648/10499/9611/4751/5347/5465/5518/5563/5564/5566/5577/6256/6608/6648/79718/203068/7531/7532	37
R-HSA-5627123	RHO GTPases activate PAKs	10/874	22/4579	0.00423670607842847	0.0112026390957516	0.00578722641802469	801/805/808/998/2017/4638/4771/5058/5062/5879	10
R-HSA-3928664	Ephrin signaling	9/874	19/4579	0.0047305183600606	0.0124504615171039	0.00643184513867888	1947/2047/2048/2049/2534/5058/5062/5879/6714	9
R-HSA-9013695	NOTCH4 Intracellular Domain Regulates Transcription	9/874	19/4579	0.0047305183600606	0.0124504615171039	0.00643184513867888	1387/2033/2324/3280/2648/8850/4851/3516/4088	9
R-HSA-5689880	Ub-specific processing proteases	40/874	142/4579	0.00490123114822078	0.0128699764792772	0.00664856443589934	154/367/408/8312/8900/890/991/993/4303/2625/9146/3091/3416/8517/2648/6885/4193/4194/4609/4792/5687/5688/5694/5717/5728/8737/79589/4086/4087/4088/4089/4092/64750/10454/6881/7046/7157/7186/7189/7314	40
R-HSA-2562578	TRIF-mediated programmed cell death	6/874	10/4579	0.00494490081339311	0.0128953032679541	0.00666164812620318	841/8772/8737/11035/148022/7099	6
R-HSA-400451	Free fatty acids regulate insulin secretion	6/874	10/4579	0.00494490081339311	0.0128953032679541	0.00666164812620318	2767/9630/2769/2776/5330/5331	6
R-HSA-9634600	Regulation of glycolysis by fructose 2,6-bisphosphate metabolism	6/874	10/4579	0.00494490081339311	0.0128953032679541	0.00666164812620318	5515/5518/5519/5528/5566/5567	6
R-HSA-112316	Neuronal System	52/874	195/4579	0.00508504789021634	0.0131830713245983	0.00681030764164779	107/108/113/1173/773/801/805/808/8536/815/816/817/818/814/84254/10645/1385/2066/2770/2773/2782/2783/10681/54331/2903/3265/3312/3845/5594/5595/4193/4893/3084/5330/5331/5562/5563/5564/5566/5567/5573/5577/5578/5579/5582/5613/5879/5923/6195/6196/6197/6714	52
R-HSA-111471	Apoptotic factor-mediated response	8/874	16/4579	0.00512481752460199	0.0131830713245983	0.00681030764164779	317/836/840/842/1029/54205/5594/5595	8
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	8/874	16/4579	0.00512481752460199	0.0131830713245983	0.00681030764164779	919/915/916/917/920/3122/3123/3932	8
R-HSA-432142	Platelet sensitization by LDL	8/874	16/4579	0.00512481752460199	0.0131830713245983	0.00681030764164779	2268/1432/5515/5518/5519/5528/5781/5777	8
R-HSA-438066	Unblocking of NMDA receptors, glutamate binding and activation	8/874	16/4579	0.00512481752460199	0.0131830713245983	0.00681030764164779	801/805/808/815/816/817/818/2903	8
R-HSA-9614657	FOXO-mediated transcription of cell death genes	8/874	16/4579	0.00512481752460199	0.0131830713245983	0.00681030764164779	10018/1387/2033/356/2308/2309/4303/6794	8
R-HSA-111461	Cytochrome c-mediated apoptotic response	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	317/836/840/842/54205/5594/5595	7
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	1869/5515/5518/5519/5925/7027/7029	7
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	207/208/10000/2064/2065/3084/7314	7
R-HSA-156711	Polo-like kinase mediated events	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	891/993/2033/2305/5347/5928/7465	7
R-HSA-202670	ERKs are inactivated	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	5594/5595/5598/5515/5518/5519/5528	7
R-HSA-5210891	Uptake and function of anthrax toxins	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	801/805/808/5604/5605/6416/5608	7
R-HSA-6804759	Regulation of TP53 Activity through Association with Co-factors	7/874	13/4579	0.00527821526915157	0.0133295342909067	0.00688596966562602	207/208/10000/10848/7157/8626/7161	7
R-HSA-111465	Apoptotic cleavage of cellular proteins	13/874	33/4579	0.00528726470114241	0.0133295342909067	0.00688596966562602	324/660/836/839/840/841/999/1499/2934/5580/5588/5747/8428	13
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	13/874	33/4579	0.00528726470114241	0.0133295342909067	0.00688596966562602	351/1147/3551/8517/6885/4790/4792/5970/6288/10454/23118/7189/7314	13
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	11/874	26/4579	0.0053579305701963	0.0134778032263566	0.00696256464408369	1147/3551/8517/6885/8737/10454/23118/7124/7132/7186/7314	11
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	14/874	37/4579	0.00588466581238786	0.0147701214761258	0.00763016968354229	472/8900/890/898/9134/1017/1026/1027/3014/3015/3159/10524/5925/7157	14
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	22/874	68/4579	0.00606902950120343	0.0151993095657892	0.00785188606925925	64682/10393/51529/29882/29945/51433/8900/890/8881/991/8697/246184/996/983/4751/5687/5688/5694/5717/7314/11065/7321	22
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	10/874	23/4579	0.0062356433703941	0.0154801888911312	0.00799698690112596	207/208/10000/2782/2783/10681/54331/5294/23533/387	10
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	10/874	23/4579	0.0062356433703941	0.0154801888911312	0.00799698690112596	2767/9630/2769/2776/2782/2783/10681/54331/1432/6714	10
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	10/874	23/4579	0.0062356433703941	0.0154801888911312	0.00799698690112596	8517/6416/6885/5602/5599/5601/10454/23118/7189/7314	10
R-HSA-8854691	Interleukin-20 family signaling	10/874	23/4579	0.0062356433703941	0.0154801888911312	0.00799698690112596	3716/3717/3718/5781/6772/6773/6774/6776/6777/7297	10
R-HSA-194315	Signaling by Rho GTPases	80/874	325/4579	0.0062960174614815	0.0155960171104672	0.00805682317052328	25/60/367/392/2909/396/397/9212/695/801/805/808/991/998/999/1027/1495/1499/2017/23002/1729/1855/1856/1857/10672/2885/3014/3015/3020/3021/3619/3688/3985/5594/5600/1432/5595/4638/653361/4690/10499/4771/25791/4928/5058/5062/5289/5296/5300/5585/5347/5515/5518/5519/5528/5578/5579/5580/5590/5747/5879/5880/5905/387/388/23433/2810/6654/6714/6722/7409/7410/10451/7514/7529/7531/7532/7533/10971/7534	80
R-HSA-4086400	PCP/CE pathway	26/874	85/4579	0.00690358031941452	0.0170638496155963	0.00881509798222724	1173/23002/1855/1856/1857/8321/2535/8322/7855/8323/8325/5578/5579/5582/5687/5688/5694/5717/5879/5880/387/4919/4920/6259/64750/7314	26
R-HSA-168927	TICAM1, RIP1-mediated IKK complex recruitment	9/874	20/4579	0.00716790789536521	0.0176787663276144	0.00913276083026324	1147/3551/8517/8737/11035/148022/7189/7314/7321	9
R-HSA-5625740	RHO GTPases activate PKNs	18/874	53/4579	0.00720018865773587	0.0177199448135188	0.00915403342678654	367/3014/3015/3020/3021/10499/5058/5585/5879/387/388/2810/7529/7531/7532/7533/10971/7534	18
R-HSA-140534	Caspase activation via Death Receptors in the presence of ligand	8/874	17/4579	0.00808452292865479	0.0198533532826793	0.0102561413986345	841/8772/355/356/8737/148022/7099/7186	8
R-HSA-453274	Mitotic G2-G2/M phases	39/874	142/4579	0.00856690965430499	0.0209926212865189	0.0108446814589432	6790/8945/8900/890/891/902/993/983/1017/1022/1026/8454/1869/2033/2305/3320/3326/4751/5347/5515/5518/5519/5520/5566/5577/5687/5688/5694/5717/5928/9978/6500/7157/203068/7314/7465/7514/7531/7532	39
R-HSA-1445148	Translocation of SLC2A4 (GLUT4) to the plasma membrane	17/874	50/4579	0.00878093266569342	0.0214707966470826	0.0110917044198233	60/207/208/801/805/808/5563/5564/5879/23433/2810/7529/7531/7532/7533/10971/7534	17
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	10/874	24/4579	0.00889683989435861	0.0217075256649909	0.0112139974272693	8517/5608/6885/5600/1432/9261/10454/23118/7189/7314	10
R-HSA-3371378	Regulation by c-FLIP	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	841/8772/355/356/8737/7186	6
R-HSA-4641265	Repression of WNT target genes	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	1487/3065/51176/6932/83439/6934	6
R-HSA-5218900	CASP8 activity is inhibited	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	841/8772/355/356/8737/7186	6
R-HSA-5357786	TNFR1-induced proapoptotic signaling	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	841/8772/8737/7124/7132/7186	6
R-HSA-69416	Dimerization of procaspase-8	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	841/8772/355/356/8737/7186	6
R-HSA-9014325	TICAM1,TRAF6-dependent induction of TAK1 complex	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	6885/10454/23118/148022/7189/7314	6
R-HSA-9020956	Interleukin-27 signaling	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	3572/3716/3717/6772/6774/7297	6
R-HSA-9022699	MECP2 regulates neuronal receptors and channels	6/874	11/4579	0.00913777341468737	0.021919089393459	0.0113232901740963	1385/2903/3065/3066/4233/25942	6
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	21/874	67/4579	0.0107476910301435	0.0257265783184698	0.0132902196007093	64682/10393/51529/29882/29945/51433/8900/890/8881/991/8697/246184/996/983/5687/5688/5694/5717/7314/11065/7321	21
R-HSA-373755	Semaphorin interactions	19/874	59/4579	0.0109580867598054	0.0261429570638311	0.0135053187442649	2909/1020/2064/2534/2932/3320/3326/3672/3688/3985/4233/5058/5062/5361/5879/387/388/6237/9037	19
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	18/874	55/4579	0.0109676257866732	0.0261429570638311	0.0135053187442649	1386/472/545/672/902/1022/1025/1111/2353/2962/2968/3725/9656/25920/5431/5432/5439/7157	18
R-HSA-69275	G2/M Transition	38/874	140/4579	0.0114643182200042	0.0272697276488385	0.0140874027015247	6790/8945/8900/890/891/902/993/983/1017/1022/1026/8454/2033/2305/3320/3326/4751/5347/5515/5518/5519/5520/5566/5577/5687/5688/5694/5717/5928/9978/6500/7157/203068/7314/7465/7514/7531/7532	38
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	8/874	18/4579	0.0121608975438991	0.0288662641073346	0.0149121653213838	801/805/808/3635/5330/5331/5335/5728	8
R-HSA-8874081	MET activates PTK2 signaling	10/874	25/4579	0.012347106017723	0.0291864023745345	0.0150775471230757	1278/2335/3082/3673/3675/3688/284217/4233/5747/6714	10
R-HSA-937041	IKK complex recruitment mediated by RIP1	10/874	25/4579	0.012347106017723	0.0291864023745345	0.0150775471230757	1147/3551/8517/8737/11035/148022/7099/7189/7314/7321	10
R-HSA-5687128	MAPK6/MAPK4 signaling	22/874	72/4579	0.0125618841023183	0.0296324942413608	0.0153079959141595	896/998/983/2308/2309/3315/3725/5597/8550/4609/8202/5058/5062/5566/5567/5687/5688/5694/5717/5879/7314/7514	22
R-HSA-69615	G1/S DNA Damage Checkpoints	20/874	64/4579	0.0130721864223983	0.0307087073213411	0.0158639621212872	472/8900/890/898/9134/993/1017/1026/1027/1029/1111/11200/4193/4194/5687/5688/5694/5717/7157/7314	20
R-HSA-75153	Apoptotic execution phase	15/874	44/4579	0.0130991407659195	0.0307087073213411	0.0158639621212872	324/660/836/839/840/841/999/1499/2934/3837/5062/5580/5588/5747/8428	15
R-HSA-9012852	Signaling by NOTCH3	15/874	44/4579	0.0130991407659195	0.0307087073213411	0.0158639621212872	1387/28514/1950/1956/2033/3280/182/2648/8850/4851/5663/3516/6772/7314/4904	15
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	19/874	60/4579	0.0132521653234258	0.0310035225776442	0.0160162621842573	641/672/1029/51564/9656/9972/8021/4928/142/8554/9063/51588/5371/9126/6672/7341/6613/6996/7329	19
R-HSA-445355	Smooth Muscle Contraction	11/874	29/4579	0.0137841588966422	0.0320920562524114	0.0165785931480309	301/302/801/805/808/3672/3693/4638/5058/5062/5829	11
R-HSA-5576892	Phase 0 - rapid depolarisation	11/874	29/4579	0.0137841588966422	0.0320920562524114	0.0165785931480309	801/805/808/815/816/817/818/2256/2257/2258/2259	11
R-HSA-164378	PKA activation in glucagon signalling	7/874	15/4579	0.0138868000670065	0.0320920562524114	0.0165785931480309	107/108/113/5566/5567/5573/5577	7
R-HSA-193639	p75NTR signals via NF-kB	7/874	15/4579	0.0138868000670065	0.0320920562524114	0.0165785931480309	3551/4790/4792/5584/5970/7189/7314	7
R-HSA-933541	TRAF6 mediated IRF7 activation	7/874	15/4579	0.0138868000670065	0.0320920562524114	0.0165785931480309	1387/2033/9641/3661/57506/7186/7189	7
R-HSA-936837	Ion transport by P-type ATPases	7/874	15/4579	0.0138868000670065	0.0320920562524114	0.0165785931480309	801/805/808/815/816/817/818	7
R-HSA-202131	Metabolism of nitric oxide: eNOS activation and regulation	6/874	12/4579	0.0153640546053133	0.035167987889184	0.0181676037977732	207/801/805/808/857/3320	6
R-HSA-209560	NF-kB is activated and signals survival	6/874	12/4579	0.0153640546053133	0.035167987889184	0.0181676037977732	3551/4790/4792/5970/7189/7314	6
R-HSA-3371511	HSF1 activation	6/874	12/4579	0.0153640546053133	0.035167987889184	0.0181676037977732	10013/3281/3297/3320/3326/7531	6
R-HSA-391160	Signal regulatory protein family interactions	6/874	12/4579	0.0153640546053133	0.035167987889184	0.0181676037977732	2885/5747/2185/5781/5777/6714	6
R-HSA-69239	Synthesis of DNA	29/874	103/4579	0.0153724626041552	0.035167987889184	0.0181676037977732	64682/10393/51529/29882/29945/51433/8900/890/898/9134/8881/8697/246184/996/1017/8454/51343/4998/5111/10714/5687/5688/5694/5717/9978/6500/7314/11065/7321	29
R-HSA-375165	NCAM signaling for neurite out-growth	15/874	45/4579	0.0162817259175664	0.0371733380889016	0.0192035575184994	1385/2260/2534/2674/2885/3265/3845/5594/5595/4893/5621/5747/9252/6654/6714	15
R-HSA-2871837	FCERI mediated NF-kB activation	23/874	78/4579	0.0168717465973898	0.0384432382389422	0.019859581481581	8945/1147/8454/2207/3551/8517/4067/6885/4790/4792/5588/5687/5688/5694/5717/10235/5970/6500/10454/23118/7189/7314/7321	23
R-HSA-6807004	Negative regulation of MET activity	8/874	19/4579	0.0175648096775998	0.039942377206862	0.0206340290528436	867/2885/3082/9146/4233/5771/5795/7314	8
R-HSA-8950505	Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation	11/874	30/4579	0.0181092213769703	0.0410981730651003	0.0212311073187298	302/375/998/3458/3586/4282/4478/5062/27250/5908/6648	11
R-HSA-9020702	Interleukin-1 signaling	28/874	100/4579	0.0183725941718269	0.0416128278353928	0.0214969753572644	351/8945/1147/8454/3551/8517/3553/3554/3557/5604/6416/5608/4215/6885/4790/4792/5687/5688/5694/5717/9978/5970/6288/6500/10454/23118/7189/7314	28
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	19/874	62/4579	0.018965515439012	0.0428703599486215	0.0221466100553912	64682/10393/51529/29882/29945/51433/8881/991/8697/246184/996/5687/5688/5694/5717/9232/7314/11065/7321	19
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	18/874	58/4579	0.0193760069128649	0.0437113489284275	0.0225810606879253	8900/890/595/898/9134/1017/1019/1026/1027/1163/8454/5687/5688/5694/5717/5753/6500/7314	18
R-HSA-4615885	SUMOylation of DNA replication proteins	13/874	38/4579	0.0196408142668767	0.0442210016266114	0.0228443446814324	6790/9212/3619/9972/8021/4928/5111/10401/51588/5905/7341/6613/7329	13
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	14/874	42/4579	0.0199447062093398	0.0448164643478644	0.0231519576967165	25/472/580/672/11200/3014/10524/5599/9656/51588/7341/7157/7314/7329	14
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	9/874	23/4579	0.020252303905865	0.0451507245901344	0.0233246348389529	1173/375/567/919/920/2534/3932/5062/5879	9
R-HSA-202040	G-protein activation	9/874	23/4579	0.020252303905865	0.0451507245901344	0.0233246348389529	2770/2773/2775/2781/2782/2783/10681/54331/5443	9
R-HSA-5260271	Diseases of Immune System	9/874	23/4579	0.020252303905865	0.0451507245901344	0.0233246348389529	695/1147/3551/8517/4790/4792/5970/148022/7099	9
R-HSA-5602358	Diseases associated with the TLR signaling cascade	9/874	23/4579	0.020252303905865	0.0451507245901344	0.0233246348389529	695/1147/3551/8517/4790/4792/5970/148022/7099	9
R-HSA-399954	Sema3A PAK dependent Axon repulsion	7/874	16/4579	0.0207016753777656	0.0457044755427564	0.0236106997665677	2534/3320/3326/5058/5062/5361/5879	7
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	7/874	16/4579	0.0207016753777656	0.0457044755427564	0.0236106997665677	2041/2247/9314/2516/4087/4089/6774	7
R-HSA-6804760	Regulation of TP53 Activity through Methylation	7/874	16/4579	0.0207016753777656	0.0457044755427564	0.0236106997665677	472/11200/2033/4193/4194/7157/7314	7
R-HSA-9008059	Interleukin-37 signaling	7/874	16/4579	0.0207016753777656	0.0457044755427564	0.0236106997665677	5781/5782/5771/5777/5778/4088/6774	7
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	7/874	16/4579	0.0207016753777656	0.0457044755427564	0.0236106997665677	6885/10454/23118/148022/7099/7189/7314	7
R-HSA-5696398	Nucleotide Excision Repair	24/874	84/4579	0.0218494700446499	0.048145053179781	0.0248714897693078	60/902/1022/10987/10980/1642/2033/2968/3150/142/5111/8554/10401/10714/5431/5432/5439/9978/54778/7341/6613/7314/7329/7528	24
R-HSA-163359	Glucagon signaling in metabolic regulation	10/874	27/4579	0.0221283826056232	0.0485713726304895	0.0250917242307209	107/108/113/2782/2783/54331/5566/5567/5573/5577	10
R-HSA-9024446	NR1H2 and NR1H3-mediated signaling	10/874	27/4579	0.0221283826056232	0.0485713726304895	0.0250917242307209	2033/8841/8648/9611/9612/8204/6256/6257/6720/79718	10
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	19/874	63/4579	0.0224567795525555	0.0491972222567546	0.0254150349666889	60/902/1022/10987/10980/1642/2968/142/5111/8554/10401/10714/9978/54778/7341/6613/7314/7329/7528	19
